<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Alpha‐2 agonists for long‐term sedation during mechanical ventilation in critically ill patients - Chen, K - 2015 | Cochrane Library</title> <meta content="Alpha‐2 agonists for long‐term sedation during mechanical ventilation in critically ill patients - Chen, K - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010269.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Alpha‐2 agonists for long‐term sedation during mechanical ventilation in critically ill patients - Chen, K - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010269.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010269.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Alpha‐2 agonists for long‐term sedation during mechanical ventilation in critically ill patients" name="citation_title"/> <meta content="Ken Chen" name="citation_author"/> <meta content="Rui Jin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="Zhijun Lu" name="citation_author"/> <meta content="Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="Yi Chun Xin" name="citation_author"/> <meta content="Rui Jin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="Yong Cai" name="citation_author"/> <meta content="School of Public Health, Shanghai Jiao Tong University" name="citation_author_institution"/> <meta content="Yi Chen" name="citation_author"/> <meta content="Shanghai Institute of Materia Medica, Chinese Academy of Sciences" name="citation_author_institution"/> <meta content="Shu Ming Pan" name="citation_author"/> <meta content="Xinhua Hospital, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="drshumingpan@gmail.com" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD010269.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/01/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010269.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010269.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010269.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Critical Illness; Adrenergic alpha‐2 Receptor Agonists [adverse effects, *therapeutic use]; Bradycardia [chemically induced]; Clonidine [therapeutic use]; Conscious Sedation [*methods]; Dexmedetomidine [adverse effects, *therapeutic use]; Lorazepam [adverse effects, therapeutic use]; Midazolam [adverse effects, therapeutic use]; Propofol [adverse effects, therapeutic use]; Randomized Controlled Trials as Topic; Respiration, Artificial [*statistics &amp; numerical data]; Selection Bias; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010269.pub2&amp;doi=10.1002/14651858.CD010269.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ZDBB8PHY";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010269\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010269\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fr","zh_HANS","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010269.pub2",title:"Alpha\\u20102 agonists for long\\u2010term sedation during mechanical ventilation in critically ill patients",firstPublishedDate:"Jan 6, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Emergency and Critical Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010269.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010269.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010269.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010269.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010269.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010269.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010269.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010269.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010269.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010269.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5989 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010269.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-sec-0089"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-sec-0071"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-sec-0083"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/appendices#CD010269-sec-0094"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/table_n/CD010269StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/table_n/CD010269StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Alpha‐2 agonists for long‐term sedation during mechanical ventilation in critically ill patients </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information#CD010269-cr-0002">Ken Chen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information#CD010269-cr-0003">Zhijun Lu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information#CD010269-cr-0004">Yi Chun Xin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information#CD010269-cr-0005">Yong Cai</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information#CD010269-cr-0006">Yi Chen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information#CD010269-cr-0007"><i class="icon corresponding-author fa fa-envelope"></i>Shu Ming Pan</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information/en#CD010269-sec-0128">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 January 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010269.pub2">https://doi.org/10.1002/14651858.CD010269.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010269-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010269-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010269-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010269-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010269-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010269-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010269-abs-0001" lang="en"> <section id="CD010269-sec-0001"> <h3 class="title" id="CD010269-sec-0001">Background</h3> <p>Sedation reduces patient levels of anxiety and stress, facilitates the delivery of care and ensures safety. Alpha‐2 agonists have a range of effects including sedation, analgesia and antianxiety. They sedate, but allow staff to interact with patients and do not suppress respiration. They are attractive alternatives for long‐term sedation during mechanical ventilation in critically ill patients. </p> </section> <section id="CD010269-sec-0002"> <h3 class="title" id="CD010269-sec-0002">Objectives</h3> <p>To assess the safety and efficacy of alpha‐2 agonists for sedation of more than 24 hours, compared with traditional sedatives, in mechanically‐ventilated critically ill patients. </p> </section> <section id="CD010269-sec-0003"> <h3 class="title" id="CD010269-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 10, 2014), MEDLINE (1946 to 9 October 2014), EMBASE (1980 to 9 October 2014), CINAHL (1982 to 9 October 2014), Latin American and Caribbean Health Sciences Literature (1982 to 9 October 2014), ISI Web of Science (1987 to 9 October 2014), Chinese Biological Medical Database (1978 to 9 October 2014) and China National Knowledge Infrastructure (1979 to 9 October 2014), the World Health Organization international clinical trials registry platform (to 9 October 2014), Current Controlled Trials metaRegister of controlled trials active registers (to 9 October 2014), the ClinicalTrials.gov database (to 9 October 2014), the conference proceedings citation index (to 9 October 2014) and the reference lists of included studies and previously published meta‐analyses and systematic reviews for relevant studies. We imposed no language restriction. </p> </section> <section id="CD010269-sec-0004"> <h3 class="title" id="CD010269-sec-0004">Selection criteria</h3> <p>We included all randomized and quasi‐randomized controlled trials comparing alpha‐2 agonists (clonidine or dexmedetomidine) versus alternative sedatives for long‐term sedation (more than 24 hours) during mechanical ventilation in critically ill patients. </p> </section> <section id="CD010269-sec-0005"> <h3 class="title" id="CD010269-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed study quality and extracted data. We contacted study authors for additional information. We performed meta‐analyses when more than three studies were included, and selected a random‐effects model due to expected clinical heterogeneity. We calculated the geometric mean difference for continuous outcomes and the risk ratio for dichotomous outcomes. We described the effects by values and 95% confidence intervals (CIs). We considered two‐sided P &lt; 0.05 to be statistically significant. </p> </section> <section id="CD010269-sec-0006"> <h3 class="title" id="CD010269-sec-0006">Main results</h3> <p>Seven studies, covering 1624 participants, met the inclusion criteria. All included studies investigated adults and compared dexmedetomidine with traditional sedatives, including propofol, midazolam and lorazepam. Compared with traditional sedatives, dexmedetomidine reduced the geometric mean duration of mechanical ventilation by 22% (95% CI 10% to 33%; four studies, 1120 participants, low quality evidence), and consequently the length of stay in the intensive care unit (ICU) by 14% (95% CI 1% to 24%; five studies, 1223 participants, very low quality evidence). There was no evidence that dexmedetomidine decreased the risk of delirium (RR 0.85; 95% CI 0.63 to 1.14; seven studies, 1624 participants, very low quality evidence) as results were consistent with both no effect and appreciable benefit. Only one study assessed the risk of coma, but lacked methodological reliability (RR 0.69; 95% CI 0.55 to 0.86, very low quality evidence). Of all the adverse events included, the most commonly reported one was bradycardia, and we observed a doubled (111%) increase in the incidence of bradycardia (RR 2.11; 95% CI 1.39 to 3.20; six studies, 1587 participants, very low quality evidence). Our meta‐analysis provided no evidence that dexmedetomidine had any impact on mortality (RR 0.99; 95% CI 0.79 to 1.24; six studies, 1584 participants, very low quality evidence). We observed high levels of heterogeneity in risk of delirium (I² = 70%), but due to the limited number of studies we were unable to determine the source of heterogeneity through subgroup analyses or meta‐regression. We judged six of the seven studies to be at high risk of bias. </p> </section> <section id="CD010269-sec-0007"> <h3 class="title" id="CD010269-sec-0007">Authors' conclusions</h3> <p>In this review, we found no eligible studies for children or for clonidine. Compared with traditional sedatives, long‐term sedation using dexmedetomidine in critically ill adults reduced the duration of mechanical ventilation and ICU length of stay. There was no evidence for a beneficial effect on risk of delirium and the heterogeneity was high. The evidence for risk of coma was inadequate. The most common adverse event was bradycardia. No evidence indicated that dexmedetomidine changed mortality. The general quality of evidence ranged from very low to low, due to high risks of bias, serious inconsistency and imprecision, and strongly suspected publication bias. Future studies could pay more attention to children and to using clonidine. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010269-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010269-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010269-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010269-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010269-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010269-abs-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010269-abs-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010269-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010269-abs-0004" lang="en"> <h3>Dexmedetomidine and clonidine for long‐term sedation during mechanical ventilation in critically ill patients </h3> <p><b>Review question</b> </p> <p>We reviewed the evidence about the safety and efficacy of dexmedetomidine and clonidine (known as alpha‐2 agonists) for long‐term sedation during mechanical ventilation in critically ill patients in the intensive care unit (ICU). </p> <p><b>Background</b> </p> <p>Sedation is an important treatment for critically ill patients who need a machine to support breathing, because it reduces anxiety and stress and facilitates the delivery of nursing care. However, some commonly‐used sedatives, such as propofol, midazolam and lorazepam, might decrease blood pressure, depress breathing, and delay awakening after a long‐term infusion. They may prolong breathing support time and length of stay in hospital. Dexmedetomidine and clonidine sedate but allow staff to interact with patients, and they ease pain but do not depress breathing. Those treated with them could be more easy to awake, and more able to communicate their discomfort and pain. These drugs are therefore attractive alternatives for long‐term sedation, and we planned to assess their efficacy and safety for long‐term (more than 24 hours) sedation, compared with traditional sedatives. </p> <p><b>Study characteristics</b> </p> <p>We searched the databases until October 2014. We included seven randomized controlled trials, with a total of 1624 participants, comparing dexmedetomidine versus traditional sedatives. All the studies required participants to have an anticipated need for sedation of more than 24 hours. The alternative sedatives included propofol, midazolam and lorazepam. We found no eligible studies in children or for clonidine. Of the seven studies, six were funded by the drug manufacturer, and one did not state any conflict of interest. </p> <p><b>Key results</b> </p> <p>Compared with traditional sedatives, dexmedetomidine reduced the breathing support time by approximately one‐fifth, and the length of stay time in ICU by one‐seventh. Dexmedetomidine was at least as effective as traditional sedatives for producing sedation and maintaining a light sedation level. There was no clear evidence in support of dexmedetomidine reducing the risk of delirium (a kind of acute confusion state), as results were consistent with both no effect and appreciable benefit. We had insufficient information to draw conclusions about reducing the risk of coma. Dexmedetomidine doubled the incidence of slow heartbeat, which was the most commonly reported adverse event. Our review provides no evidence that dexmedetomidine changed the overall death rate. </p> <p><b>Quality of the evidence</b> </p> <p>The general quality of evidence ranged from very low to low, as most of the studies were at high risk of bias, serious inconsistency and imprecision, or strongly suspected publication bias. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010269-sec-0089" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010269-sec-0089"></div> <h3 class="title" id="CD010269-sec-0090">Implications for practice</h3> <section id="CD010269-sec-0090"> <p>In this review, we found the use of dexmedetomidine for long‐term sedation in critically ill, mechanically‐ventilated adults could help to reduce ventilation time and intensive care unit (ICU) length of stay. The premise behind this beneficial effect might be that medical staff carefully administered dexmedetomidine based on sedation level assessment, used a light level of sedation protocols, treated pain during sedation, and routinely monitored delirium. There was no evidence to support the use of dexmedetomidine in reducing risk of delirium, and inadequate evidence for it reducing the risk of coma. The most common adverse event of dexmedetomidine was bradycardia, but in most cases the bradycardiac effect was harmless and did not need to be treated. Dexmedetomidine was as effective as traditional sedatives for producing sedation and maintaining a light sedation level (a RASS score greater than or equal to ‐3). However, it might be a poor choice for a deeper sedation; even for light sedation, dexmedetomidine might still result in insufficient sedation in approximately one in every eight to 10 patients. We failed to identify any evidence concerning reducing duration of weaning or overall mortality. </p> </section> <h3 class="title" id="CD010269-sec-0091">Implications for research</h3> <section id="CD010269-sec-0091"> <p>In this review, we found no eligible studies investigating clonidine, although a pilot randomized controlled trial (RCT) has shown clonidine to be as safe and effective as dexmedetomidine in critically ill patients (<a href="./references#CD010269-bbs2-0100" title="MachadoFO , MoritzRD , BerbigierEJ , BerbigierRJ . Comparison between clonidine and dexmedetomidine for sedation and analgesia in critically ill patients. Intensive Care Medicine. 2011; Vol. Conference: 24th Annual Congress of the European Society of Intensive Care Medicine, ESICM LIVES 2011 Berlin Germany. ">Machado 2011</a>). There is therefore a need for a larger prospective study which could evaluate the efficacy, safety and cost effectiveness of clonidine for long‐term sedation. We found no studies in children, although many retrospective studies have shown the efficacy and safety of alpha‐2 agonists in children (<a href="./references#CD010269-bbs2-0008" title="Arenas‐LopézS , RiphagenS , TibbySM , DurwardA , TomlinS , DaviesG , et al. Use of oral clonidine for sedation in ventilated paediatric intensive care patients. Intensive Care Medicine2004;30(8):1625‐9. [PUBMED: 15197439] ">Arenas 2004</a>; <a href="./references#CD010269-bbs2-0068" title="CarneyL , KendrickJ , CarrR . Safety and Effectiveness of Dexmedetomidine in the Pediatric Intensive Care Unit (SAD‐PICU). Canadian Society of Hospital Pharmacists2013;66(1):21‐7. [PUBMED: 23467635] ">Carney 2013</a>; <a href="./references#CD010269-bbs2-0070" title="CzajaAS , ZimmermanJJ . The use of dexmedetomidine in critically ill children. Paediatric Critical Care Medicine2009;10(3):381‐6. [PUBMED: 19325505] ">Czaja 2009</a>; <a href="./references#CD010269-bbs2-0081" title="GuptaP , WhitesideW , SabatiA , TesoroTM , GossettJM , TobiasJD , et al. Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease. Pediatric Critical Care Medicine2012;13(6):660‐6. [PUBMED: 22791093] ">Gupta 2012</a>). Future RCTs of alpha‐2 agonists could be conducted in children. Although our systematic review includes a broad range of populations, some confounding factors, such as participants' physical characteristics, medical conditions and reasons for ventilation, might affect the magnitude of the intervention effects. For example, participants with sepsis might benefit more from dexmedetomidine than those without sepsis (<a href="./references#CD010269-bbs2-0111" title="PandharipandePP , SandersRD , GirardTD , McGraneS , ThompsonJL , ShintaniAK , et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori‐designed analysis of the MENDS randomized controlled trial. Critical Care2010;14(2):R38. [PUBMED: 20233428] ">Pandharipande 2010</a>). Future studies could focus more directly on specific populations, such as people with chronic obstructive pulmonary disease (COPD), people with adult respiratory distress syndrome (ARDS) or brain‐injured people. We observed a high level of heterogeneity for the risk of delirium, which may be associated with the imprecision of the screening tool. Future studies evaluating the efficacy of alpha‐2 agonists for ICU delirium could stratify randomized participants by similar risks, could use more validated diagnostic tools, and could focus on long‐term cognitive outcomes. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010269-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010269-sec-0036"></div> <div class="table" id="CD010269-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Dexmedetomidine compared to traditional sedative agents for long‐term sedation during mechanical ventilation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Dexmedetomidine compared to traditional sedative agents for long‐term sedation during mechanical ventilation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Critically ill patients requiring long‐term sedation during mechanical ventilation<br/> <b>Settings:</b> ICUs<br/> <b>Intervention:</b> Dexmedetomidine<br/> <b>Comparison:</b> traditional sedative agents </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>traditional sedative agents</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Dexmedetomidine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of mechanical ventilation</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Relative decrease 22% in the geometric mean (95% CI 10% to 33%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1120<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Alpha‐2 agonists reduced geometric mean duration of mechanical ventilation by 0.25 (95% CI 0.10 to 0.40), corresponding to a reduction of 22% in the geometric mean (95% CI 10% to 33%). The relative change in geometric means usually produces similar results to the relative change in arithmetic means. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Risk of delirium</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 0.85<br/> (0.63 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1624<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3,4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>‐</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>266 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>226 per 1000<br/> (167 to 303) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>76 per 1000 <sup>8</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000<br/> (48 to 87) <sup>8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>824 per 1000 <sup>8</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>700 per 1000<br/> (519 to 939) <sup>8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of coma</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.69<br/> (0.55 to 0.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>103<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1,2,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>922 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>636 per 1000<br/> (507 to 793) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Incidence of bradycardia</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 2.11<br/> (1.39 to 3.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1587<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>10,7,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000<br/> (124 to 287) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>39 per 1000 <sup>8</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000<br/> (54 to 125) <sup>8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>188 per 1000 <sup>8</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>397 per 1000<br/> (261 to 602) <sup>8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of weaning</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only one study assessed this outcome and only reported median and range. We were not able to estimate a relative effect. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU length of stay</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Relative decrease 14% in the geometric mean (95% CI 0.01% to 24%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1223<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1,11,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation using alpha‐2 agonists reduced geometric mean ICU LOS by 0.15 (95% CI 0.01 to 0.28), corresponding to a reduction of 14% in the geometric mean (95% CI 0.01% to 24%). Relative change in geometric means usually produces similar results to the relative change in arithmetic means. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.99<br/> (0.79 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1584<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>10,5,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>205 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1000<br/> (162 to 254) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>192 per 1000 <sup>12</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>190 per 1000<br/> (152 to 238) <sup>12</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 1 point due to all the studies being at high risk of bias, which was considered very serious. </p> <p><sup>2</sup>Downgraded by 1 point because all the studies received funding support from pharmaceutical firms and thus publication bias was strongly suspected. </p> <p><sup>3</sup>Downgraded by 1 point due to 6 of the 7 studies being at high risk of bias, which was considered serious. </p> <p><sup>4</sup>Downgraded by 1 point because the heterogeneity is substantial and thus inconsistency was serious. </p> <p><sup>5</sup>Downgraded by 1 point because results were consistent with both no effect and appreciable benefit, and thus imprecision was serious. </p> <p><sup>6</sup>Downgraded by 1 point because 6 of the 7 studies received funding support from pharmaceutical firms and thus publication bias was strongly suspected. </p> <p><sup>7</sup>Downgraded by 1 point because the sample size was small (less than 2000) and thus inconsistency was serious. </p> <p><sup>8</sup>The baseline risk varies broadly among studies, and thus we chose the lowest and highest control group risk in the included studies. </p> <p><sup>9</sup>Downgraded by 1 point due to 5 of the 6 studies being at high risk of bias, which was considered serious. </p> <p><sup>10</sup>Downgraded by 1 point because 5 of the 6 studies received funding support from pharmaceutical firms and thus publication bias was strongly suspected. </p> <p><sup>11</sup>Downgraded by 1 point due to wide confidence interval, although there may still be enough precision to make decisions about the utility of the intervention. </p> <p><sup>12</sup>There was little variation in the baseline risk across the studies, and thus we calculated the median control group risk. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010269-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010269-sec-0037"></div> <section id="CD010269-sec-0038"> <h3 class="title" id="CD010269-sec-0038">Description of the condition</h3> <p>Sedation has become an important treatment in intensive care settings, especially for those undergoing mechanical ventilation. In the United States, half of patients with mechanical ventilation received intravenous sedation for more than 70% of their ventilation time (<a href="./references#CD010269-bbs2-0133" title="WunschH , KahnJM , KramerAA , RubenfeldGD . Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Critical Care Medicine2009;37(12):3031‐9. [PUBMED: 19633543] ">Wunsch 2009</a>). Sedation could reduce levels of anxiety and stress, facilitate the delivery of nursing care, prevent self extubation and ensure synchrony with mechanical ventilation (<a href="./references#CD010269-bbs2-0078" title="GehlbachBK , KressJP . Sedation in the intensive care unit. Current Opinion in Critical Care2002;8(4):290‐8. [PUBMED: 12386488] ">Gehlbach 2002</a>). </p> <p>Most physicians choose propofol and benzodiazepines for long‐term sedation (<a href="./references#CD010269-bbs2-0106" title="MehtaS , McCullaghI , BurryL . Current sedation practices: lessons learned from international surveys. Critical Care Clinics2011;29(4):607‐24. [PUBMED: 19576525] ">Mehta 2011</a>). Propofol is fast onset and offset, but decreases blood pressure, and may cause lipid metabolism disorder and fatal propofol infusion syndrome after long‐term use (<a href="./references#CD010269-bbs2-0097" title="KamPC , CardoneD . Propofol infusion syndrome. Anaesthesia2007;62(7):690‐701. [PUBMED: 17567345] ">Kam 2007</a>; <a href="./references#CD010269-bbs2-0107" title="MillerLJ , Wiles‐PfeiflerR . Propofol for the long‐term sedation of a critically ill patient. American Journal of Critical Care1998;7(1):73‐6. [PUBMED: 9429686] ">Miller 1998</a>). Although benzodiazepines have little effect on blood pressure, they may cause apnoea and respiratory depression (<a href="./references#CD010269-bbs2-0131" title="WatlingSM , JohnsonM , YanosJ . A method to produce sedation in critically ill patients. The Annals of Pharmacotherapy1996;30(11):1227‐31. [PUBMED: 8913400] ">Watling 1996</a>). Benzodiazepines tend to be accumulated in body tissues and thus lead to delayed awakening (<a href="./references#CD010269-bbs2-0118" title="ShellyMP , SultanMA , BodenhamA , ParkGR . Midazolam infusions in critically ill patients. European Journal of Anaesthesiology1991;8(1):21‐7. [PUBMED: 1678701] ">Shelly 1991</a>). Furthermore, benzodiazepines might be associated with high risks of delirium and coma (<a href="./references#CD010269-bbs2-0057" title="AgarwalV , O'NeillPJ , CottonBA , PunBT , HaneyS , ThompsonJ , et al. Prevalence and risk factors for development of delirium in burn intensive care unit patients. Journal of Burn Care &amp; Research2010;31(5):706‐15. [PUBMED: 20647937] ">Agarwal 2010</a>; <a href="./references#CD010269-bbs2-0109" title="PandharipandeP , ShintaniA , PetersonJ , PunBT , WilkinsonGR , DittusRS , et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology2006;104(1):21‐6. [PUBMED: 16394685] ">Pandharipande 2006</a>; <a href="./references#CD010269-bbs2-0110" title="PandharipandeP , CottonBA , ShintaniA , ThompsonJ , PunBT , MorrisJAJ , et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. Journal of Trauma‐Injury Infection &amp; Critical Care2008;65(1):34‐41. [PUBMED: 18580517] ">Pandharipande 2008;</a><a href="./references#CD010269-bbs2-0132" title="WatsonPL , ShintaniAK , TysonR , PandharipandePP , PunBT , ElyEW . Presence of electroencephalogram burst suppression in sedated, critically ill patients is associated with increased mortality. Critical Care Medicine2008;36(12):3171‐7. [PUBMED: 19020432] ">Watson 2008</a>), which increase ventilation time, mortality and healthcare costs (<a href="./references#CD010269-bbs2-0074" title="DuboisMJ , BergeronN , DumontM , DialS , SkrobikY . Delirium in an intensive care unit: a study of risk factors. Intensive Care Medicine2001;27(8):1297‐304. [PUBMED: 11511942] ">Dubois 2001</a>; <a href="./references#CD010269-bbs2-0075" title="ElyEW , ShintaniA , TrumanB , SperoffT , GordonSM , HarrellFEJ , et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA2004;291(14):1753‐62. [PUBMED: 15082703] ">Ely 2004</a>). </p> <p>Increasingly, many institutions use sedation strategies, such as nursing‐implemented sedation protocols and daily interruption to minimize the use of sedatives and limit the adverse events. These strategies reduce the dosage of sedatives, ventilation time and intensive care unit length of stay (ICU LOS) (<a href="./references#CD010269-bbs2-0059" title="AitkenLM , BucknallT , KentB , MitchellM , BurmeisterE , KeoghSJ . Protocol directed sedation versus non‐protocol directed sedation to reduce duration of mechanical ventilation in mechanically ventilated intensive care patients. Cochrane Database of Systematic Reviews2012, Issue 4. [DOI: 10.1002/14651858.CD009771] ">Aitken 2012</a>; <a href="./references#CD010269-bbs2-0066" title="BrookAD , AhrensTS , SchaiffR , PrenticeD , ShermanG , ShannonW , et al. Effect of a nursing‐implemented sedation protocol on the duration of mechanical ventilation. Critical Care Medicine1999;27(12):2609‐15. [PUBMED: 10628598] ">Brook 1999</a>; <a href="./references#CD010269-bbs2-0067" title="BurryL , RoseL , McCullaghI , FergusonND , FergusonD , MehtaS . Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation. Cochrane Database of Systematic Reviews2014, Issue 7. [DOI: 10.1002/14651858.CD009176.pub2] ">Burry 2014</a>; <a href="./references#CD010269-bbs2-0079" title="GirardTD , KressJP , FuchsBD , ThomasonJW , SchweickertWD , PunBT , et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. The Lancet2008;371(9607):126–34. [PUBMED: 18191684] ">Girard 2008</a>), but lack of physicians' specific order and nursing acceptance have prevented them from being widely adopted. A survey of members of the Society of Critical Care Medicine showed that only 64% of respondents used sedation protocols, and 40% used interruption of sedation every day (<a href="./references#CD010269-bbs2-0123" title="TaniosMA , DeWitM , EpsteinSK , DevlinJW . Perceived barriers to the use of sedation protocols and daily sedation interruption: a multidisciplinary survey. Journal of Critical Care2009;24(1):66‐73. [PUBMED: 19272541] ">Tanios 2009</a>). Moreover, even when physicians applied sedation strategies, the choice of sedatives ‐ for example, using short‐acting, non‐benzodiazepine sedatives rather than benzodiazepines ‐ could still affect the ventilation time and hospital stay (<a href="./references#CD010269-bbs2-0069" title="CarsonSS , KressJP , RodgersJE , VinayakA , Campbell‐BrightS , LevittJ , et al. A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Critical Care Medicine2006;34(5):1326‐32. [PUBMED: 16540958] ">Carson 2006</a>; <a href="./references#CD010269-bbs2-0111" title="PandharipandePP , SandersRD , GirardTD , McGraneS , ThompsonJL , ShintaniAK , et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori‐designed analysis of the MENDS randomized controlled trial. Critical Care2010;14(2):R38. [PUBMED: 20233428] ">Pandharipande 2010</a>). This is probably because these sedatives are easy to titrate and rapid to wake from, which in turn helps to finish sedation protocols and daily interruption. </p> <p>Results from recent studies suggest that a strategy of light sedation could reduce ventilation time and ICU LOS (<a href="./references#CD010269-bbs2-0117" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early intensive care sedation predicts long‐term mortality in ventilated critically ill patients. American Journal of Respiratory and Critical Care Medicine2012;186(8):724‐31. [PUBMED: 22859526] ">Shehabi 2012</a>; <a href="./references#CD010269-bbs2-0127" title="TreggiariMM , RomandJA , YanezND , DeemSA , GoldbergJ , HudsonL , et al. Randomized trial of light versus deep sedation on mental health after critical illness. Critical Care Medicine2009;37(9):2527‐34. [PUBMED: 19602975] ">Treggiari 2009</a>). In addition, many investigators also recommend that any sedation strategy should incorporate analgesia, due to the difficulty of determining pain in critically ill patients (<a href="./references#CD010269-bbs2-0076" title="FraserGL , RikerRR . Sedation and analgesia in the critically ill adult. Current Opinion in Anaesthesiology2007;20(2):119‐23. [PUBMED: 17413394] ">Fraser 2007</a>) and the favourable results in shorter ventilation time, weaning time and ICU LOS (<a href="./references#CD010269-bbs2-0065" title="BreenD , KarabinisA , MalbrainM , MoraisR , AlbrechtS , JarnvigIL , et al. Decreased duration of mechanical ventilation when comparing analgesia‐based sedation using remifentanil with standard hypnotic‐based sedation for up to 10 days in intensive care unit patients: a randomised trial. Critical Care2005;9(3):R200‐10. [PUBMED: 15987391] ">Breen 2005</a>). A randomized controlled trial (RCT) found that when all the participants received intravenous analgesia (morphine), those with no infusion of sedatives had shorter ventilation time and ICU LOS, although more occurrences of delirium, than those with protocolized sedation and daily interruption (<a href="./references#CD010269-bbs2-0121" title="StromT , MartinussenT , ToftP . A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet2010;375(9713):475‐80. [PUBMED: 20116824] ">Strom 2010</a>). The 'protocol of no sedation' in <a href="./references#CD010269-bbs2-0121" title="StromT , MartinussenT , ToftP . A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet2010;375(9713):475‐80. [PUBMED: 20116824] ">Strom 2010</a> was not really a protocol without any sedation, since morphine has a mild sedative effect, but it explored new challenges for sedation management: whenever possible, using the minimum level of sedation, providing adequate pain control and making a careful trade‐off between the level of sedation and the patient's comfort and safety. A sedative agent that provided lighter sedation, less pain and fewer adverse events would therefore be an attractive alternative. </p> </section> <section id="CD010269-sec-0039"> <h3 class="title" id="CD010269-sec-0039">Description of the intervention</h3> <p>Alpha‐2 agonists have a wide range of effects including sedation, analgesia and relief of anxiety (<a href="./references#CD010269-bbs2-0102" title="MantzJ , JosserandJ , HamadaS . Dexmedetomidine: new insights. European Journal of Anaesthesiology2011;28(1):3‐6. [PUBMED: 20881501] ">Mantz 2011</a>; <a href="./references#CD010269-bbs2-0112" title="PichotC , GhignoneM , QuintinL . Dexmedetomidine and clonidine: from second‐to‐first‐line sedative agents in the critical care setting?. Journal of Intensive Care Medicine2012;27(4):219‐37. [PUBMED: 21525113] ">Pichot 2012</a>). These effects are mainly mediated though adrenoceptors of the alpha‐2a subtype, which are distributed in the locus coeruleus (<a href="./references#CD010269-bbs2-0080" title="GregorettiC , MogliaB , PelosiP , NavalesiP . Clonidine in perioperative medicine and intensive care unit: more than an anti‐hypertensive drug. Current Drug Targets2009;10(8):799‐814. [PUBMED: 19702526] ">Gregoretti 2009</a>; <a href="./references#CD010269-bbs2-0102" title="MantzJ , JosserandJ , HamadaS . Dexmedetomidine: new insights. European Journal of Anaesthesiology2011;28(1):3‐6. [PUBMED: 20881501] ">Mantz 2011</a>). Unlike benzodiazepines and propofol, which inhibit the neurons in the central nervous system, alpha‐2 agonists reduce the activity but preserve the reactivity of neurons in the locus coeruleus. Alpha‐2 agonists therefore sedate but allow staff to interact with patients and do not suppress the respiratory drive. Alpha‐2 agonists might also be involved in neuroprotection and inflammatory responses, which may potentially help protect against the occurrence of delirium or coma (<a href="./references#CD010269-bbs2-0102" title="MantzJ , JosserandJ , HamadaS . Dexmedetomidine: new insights. European Journal of Anaesthesiology2011;28(1):3‐6. [PUBMED: 20881501] ">Mantz 2011</a>). The adverse events of alpha‐2 agonists, such as bradycardia and hypotension, are mediated via adrenoceptors of the alpha‐2 in the medullary dorsal motor nucleus and motor complex, and are thus independent of sedative effect (<a href="./references#CD010269-bbs2-0080" title="GregorettiC , MogliaB , PelosiP , NavalesiP . Clonidine in perioperative medicine and intensive care unit: more than an anti‐hypertensive drug. Current Drug Targets2009;10(8):799‐814. [PUBMED: 19702526] ">Gregoretti 2009</a>; <a href="./references#CD010269-bbs2-0112" title="PichotC , GhignoneM , QuintinL . Dexmedetomidine and clonidine: from second‐to‐first‐line sedative agents in the critical care setting?. Journal of Intensive Care Medicine2012;27(4):219‐37. [PUBMED: 21525113] ">Pichot 2012</a>). </p> <p>Clonidine and dexmedetomidine are two extensively‐studied alpha‐2 agonists, and both have similar mechanisms and adverse events. Although physicians have used clonidine to treat hypertension and acute withdrawal syndrome (<a href="./references#CD010269-bbs2-0064" title="BohrerH , BachA , LayerM , WerningP . Clonidine as a sedative adjunct in intensive care. Intensive Care Medicine1990;16(4):265‐6. [PUBMED: 2358560] ">Bohrer 1990</a>; <a href="./references#CD010269-bbs2-0080" title="GregorettiC , MogliaB , PelosiP , NavalesiP . Clonidine in perioperative medicine and intensive care unit: more than an anti‐hypertensive drug. Current Drug Targets2009;10(8):799‐814. [PUBMED: 19702526] ">Gregoretti 2009</a>), or have used it as an anaesthetic adjuvant (<a href="./references#CD010269-bbs2-0071" title="DahmaniS , BrasherC , StanyI , GolmardJ , SkhiriA , BruneauB , et al. Premedication with clonidine is superior to benzodiazepines. A meta analysis of published studies. Acta Anaesthesiologica Scandinavica2010;54(4):397‐402. [PUBMED: 20085541] ">Dahmani 2010</a>; <a href="./references#CD010269-bbs2-0080" title="GregorettiC , MogliaB , PelosiP , NavalesiP . Clonidine in perioperative medicine and intensive care unit: more than an anti‐hypertensive drug. Current Drug Targets2009;10(8):799‐814. [PUBMED: 19702526] ">Gregoretti 2009</a>; <a href="./references#CD010269-bbs2-0098" title="LambertP , CynaAM , KnightN , MiddletonP . Clonidine premedication for postoperative analgesia in children. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD009633.pub2] ">Lambert 2014</a>), its use for sedation remains 'off label' in many countries. Dexmedetomidine has a higher alpha‐2/alpha‐1 selectivity ratio (dexmedetomidine 1620:1, clonidine 220:1) (<a href="./references#CD010269-bbs2-0130" title="VirtanenR , SavolaJM , SaanoV , NymanL . Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2‐adrenoceptor agonist. European Journal of Pharmacology1988;150(1‐2):9‐14. [PUBMED: 2900154] ">Virtanen 1988</a>). The US Food and Drug Administration (FDA) authorized it for sedation during mechanical ventilation in 1999, and it can also be used as an analgesic adjuvant for acute postoperative pain control (<a href="./references#CD010269-bbs2-0058" title="AhoMS , ErkolaOA , ScheininH , LehtinenAM , KorttilaKT . Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesthesia and Analgesia1991;73(2):112‐8. [PUBMED: 1854025] ">Aho 1991</a>; <a href="./references#CD010269-bbs2-0096" title="Jessen LundorfL , Korvenius JørgensenH , MøllerAM . Perioperative dexmedetomidine for acute pain after abdominal surgery in adults. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD010358] ">Jessen 2013</a>). Dexmedetomidine is now available in the United States, Asia, the Middle East, Australia and Europe (<a href="./references#CD010269-bbs2-0102" title="MantzJ , JosserandJ , HamadaS . Dexmedetomidine: new insights. European Journal of Anaesthesiology2011;28(1):3‐6. [PUBMED: 20881501] ">Mantz 2011</a>; <a href="./references#CD010269-bbs2-0112" title="PichotC , GhignoneM , QuintinL . Dexmedetomidine and clonidine: from second‐to‐first‐line sedative agents in the critical care setting?. Journal of Intensive Care Medicine2012;27(4):219‐37. [PUBMED: 21525113] ">Pichot 2012</a>). </p> <p>Clonidine is usually administered to adults intravenously at a dose of 2 mcg/kg per hour, or given as a bolus of 50 mcg to 150 mcg every eight hours (<a href="./references#CD010269-bbs2-0093" title="IseT , YamashiroM , FuruyaH . Clonidine as a drug for intravenous conscious sedation. Odontology/the Society of the Nippon Dental University2002;90(1):57‐63. [PUBMED: 12955567] ">Ise 2002</a>; <a href="./references#CD010269-bbs2-0095" title="JamadarkhanaS , GopalS . Clonidine in adults as a sedative agent in the intensive care unit. Journal of Anaesthesiology, Clinical Pharmacology2010;26(4):439‐45. [PUBMED: 21547166] ">Jamadarkhana 2010</a>). The oral dose of clonidine is 50 mcg to 600 mcg every eight hours (<a href="./references#CD010269-bbs2-0095" title="JamadarkhanaS , GopalS . Clonidine in adults as a sedative agent in the intensive care unit. Journal of Anaesthesiology, Clinical Pharmacology2010;26(4):439‐45. [PUBMED: 21547166] ">Jamadarkhana 2010</a>). The maintenance infusion rate of dexmedetomidine is 0.2 mcg/kg per hour to 0.7 mcg/kg per hour, for less than 24 hours (<a href="./references#CD010269-bbs2-0113" title="Precedex prescribing information. www.precedex.com/safety/full‐prescribing‐information (Accessed 31st October 2012). ">Precedex Prescribing Information</a>). </p> </section> <section id="CD010269-sec-0040"> <h3 class="title" id="CD010269-sec-0040">How the intervention might work</h3> <p>Several RCTs showed alpha‐2 agonists for long‐term sedation reduced the duration of mechanical ventilation compared with traditional sedatives (<a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0119" title="SpiesCD , OtterHE , HuskeB , SinhaP , NeumannT , RettigJ , et al. Alcohol withdrawal severity is decreased by symptom‐orientated adjusted bolus therapy in the ICU. Intensive Care Medicine2003;29(12):2230‐8. [PUBMED: 14557857] ">Spies 2003</a>). Two aspects of alpha‐2 agonists might be related to this reduction: one could be that people treated with alpha‐2 agonists were more arousable, easier to communicate with and more able to express pain and needs (<a href="./references#CD010269-bbs2-0103" title="MartinE , RamsayG , MantzJ , Sum‐PingST . The role of the alpha2‐adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. Journal of Intensive Care Medicine2003;18(1):29‐41. [PUBMED: 15189665] ">Martin 2003</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>). The analgesia‐based sedation retained spontaneous respiration, and facilitated the delivery of care and the implementation of spontaneous breathing trials (<a href="./references#CD010269-bbs2-0061" title="BaileyPL , SperryRJ , JohnsonGK , EldredgeSJ , EastKA , EastTD , et al. Respiratory effects of clonidine alone and combined with morphine, in humans. Anesthesiology1991;74(1):43‐8. [PUBMED: 1898841] ">Bailey 1991</a>; <a href="./references#CD010269-bbs2-0083" title="HallJE , UhrichTD , BarneyJA , ArainSR , EbertTJ . Sedative, amnestic, and analgesic properties of small‐dose dexmedetomidine infusions. Anesthesia and Analgesia2000;90(3):699‐705. [PUBMED: 10702460] ">Hall 2000</a>; <a href="./references#CD010269-bbs2-0084" title="HallJE , UhrichTD , EbertTJ . Sedative, analgesic and cognitive effects of clonidine infusions in humans. British Journal of Anaesthesia2001;86(1):5‐11. [PUBMED: 11575409] ">Hall 2001</a>; <a href="./references#CD010269-bbs2-0091" title="HsuYW , CortinezLI , RobertsonKM , KeiferJ‐C , Sum‐PingST , MorettiEW , et al. Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology2004;101(5):1066‐76. [PUBMED: 15505441] ">Hsu 2004</a>). A second aspect could be that alpha‐2 agonists were associated with fewer occurrence of delirium and coma (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0115" title="RubinoAS , OnoratiF , CaroleoS , GalatoE , NuceraS , AmanteaB , et al. Impact of clonidine administration on delirium and related respiratory weaning after surgical correction of acute type‐A aortic dissection: results of a pilot study. Interactive Cardiovascular and Thoracic Surgery2010;10(1):58‐62. [PUBMED: 19854793] ">Rubino 2010</a>), probably because they work differently to propofol and benzodiazepines, and provide sleep‐like sedation (<a href="./references#CD010269-bbs2-0092" title="HuupponenE , MaksimowA , LapinlampiP , SärkeläM , SaastamoinenA , SnapirA , et al. Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiologica Scandinavica2008; Vol. 52, issue 2:289‐94. [PUBMED: 18005372] ">Huupponen 2008</a>; <a href="./references#CD010269-bbs2-0104" title="MasonKP , O'MahonyE , ZurakowskiD , LibensonMH . Effects of dexmedetomidine sedation on the EEG in children. Paediatric Anaesthesia2009;19(12):1175‐83. [PUBMED: 20017865] ">Mason 2009</a>). </p> </section> <section id="CD010269-sec-0041"> <h3 class="title" id="CD010269-sec-0041">Why it is important to do this review</h3> <p>Although some RCTs of long‐term sedation suggest that alpha‐2 agonists could reduce the duration of mechanical ventilation and delirium, other RCTs disagree: they found no improvement in ventilation time (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>) and even a higher incidence of delirium (<a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>). The FDA did not approve clonidine for sedation and only authorized dexmedetomidine infusions for less than 24 hours. There was therefore no way to know whether they were safe and effective for longer sedation. A previous meta‐analysis assessed the effects of dexmedetomidine in critically ill patients and found no difference in ventilation time or incidence of delirium compared with traditional sedatives or placebo (<a href="./references#CD010269-bbs2-0122" title="TanJA , HoKM . Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta‐analysis. Intensive Care Medicine2010;36(6):926‐39. [PUBMED: 20376429] ">Tan 2010</a>). But a number of RCTs have been published since its last search in 2009 (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>), and a comment on that meta‐analysis pointed out flaws in methodology (for example, unit‐of‐analyses error, confusion of agitation with delirium, and inadequate investigation of heterogeneity), which weaken the value of its results (<a href="./references#CD010269-bbs2-0124" title="TejaniAM , SchwengerE . Comment on dexmedetomidine systematic review and meta‐analysis methodology. Intensive Care Medicine2010;36(11):1974; author reply 1975. [PUBMED: 20689913] ">Tejani 2010</a>). They included RCTs investigating both short‐term and long‐term sedation, but most were short‐term, and thus provided limited information on long‐term safety and efficacy. </p> <p>Despite the theoretical advantages of alpha‐2 agonists, their safety and efficacy for long‐term use remain controversial. We also consider that people undergoing long‐term ventilation and sedation are substantially different from those receiving short‐term treatment; they have a different disease spectrum, are more critically ill, need more dosage of sedatives, are more exposed to the adverse events of sedatives, and are more likely to wake up later. A comprehensive synthesis is therefore needed to assess whether alpha‐2 agonists are safe and whether they have advantages over traditional sedatives for long‐term sedation, by reducing the duration of mechanical ventilation and the risks of delirium and coma. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010269-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010269-sec-0042"></div> <p>To assess the safety and efficacy of alpha‐2 agonists for sedation of more than 24 hours, compared with traditional sedatives, in mechanically‐ventilated critically ill patients. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010269-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010269-sec-0043"></div> <section id="CD010269-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010269-sec-0045"> <h4 class="title">Types of studies</h4> <p>We include all randomized and quasi‐randomized controlled trials. Quasi‐randomized controlled trials include those trials that use inappropriate randomization strategies (e.g. alternation, birth date, hospital registration number, etc.) (<a href="./references#CD010269-bbs2-0088" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboratio, 2011. available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). </p> <p>We exclude cluster‐randomized, cross‐over and non‐randomized trials.</p> </section> <section id="CD010269-sec-0046"> <h4 class="title">Types of participants</h4> <p>We include randomized controlled trials (RCTs) of critically ill participants of any age, except neonates, who required intensive care and invasive mechanical ventilation when recruited. </p> <p>We exclude RCTs in which participants only had non‐invasive mechanical ventilation.</p> </section> <section id="CD010269-sec-0047"> <h4 class="title">Types of interventions</h4> <p>We include studies comparing clonidine or dexmedetomidine versus alternative sedative agents. The alternative sedatives included benzodiazepines, such as midazolam or diazepam, propofol and other sedatives. </p> <p>We include studies which explicitly report that each participant was anticipated to need sedation for more than 24 hours. There was no limitation for dose, frequency or route of administration of alpha‐2 agonists. </p> <p>We exclude studies in which all participants were sedated for less than 24 hours or studies without an explicit statement that they required or anticipated participants to have sedation for more than 24 hours . We exclude studies that compare one alpha‐2 agonist with another. </p> </section> <section id="CD010269-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD010269-sec-0049"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010269-list-0001"> <li> <p>Duration of mechanical ventilation (as defined by authors of the studies).</p> </li> <li> <p>Risk of delirium, measured with any diagnostic criteria, such as the confusion assessment method for the intensive care unit (CAM‐ICU). </p> </li> <li> <p>Risk of coma (as defined by authors of the studies).</p> </li> </ol> </p> </section> <section id="CD010269-sec-0050"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010269-list-0002"> <li> <p>Adverse events:</p> <ol id="CD010269-list-0003"> <li> <p>incidence of bradycardia (as defined by authors of the studies);</p> </li> <li> <p>incidence of hypotension (as defined by authors of the studies);</p> </li> <li> <p>incidence of hypertension (as defined by authors of the studies);</p> </li> <li> <p>any other adverse events.</p> </li> </ol> </li> <li> <p>Proportion of sedation time spent at target sedation level (as defined by authors of the studies). </p> </li> <li> <p>Duration of weaning (time from weaning to extubation as defined by authors of the studies). </p> </li> <li> <p>intensive care unit length of stay (ICU LOS).</p> </li> <li> <p>Mortality; if mortality is assessed at various follow‐up times (e.g. ICU mortality, 30‐day mortality, one‐year mortality), we will include only the one that most closely approximates to that used in the other included studies. </p> </li> </ol> </p> </section> </section> </section> <section id="CD010269-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010269-sec-0052"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL, <i>The Cochrane Library</i>, Issue 10, 2014; see <a href="./appendices#CD010269-sec-0095">Appendix 1</a> for detailed search strategy), MEDLINE (Ovid SP, 1946 to 9 October 2014; see <a href="./appendices#CD010269-sec-0096">Appendix 2</a>), EMBASE (Ovid SP, 1980 to 9 October 2014; see <a href="./appendices#CD010269-sec-0097">Appendix 3</a>), CINAHL (EBSCO host, 1982 to 9 October 2014; see <a href="./appendices#CD010269-sec-0098">Appendix 4</a>), Latin American and Caribbean Health Sciences Literature (LILACS, via BIREME interface, 1982 to 9 October 2014; see <a href="./appendices#CD010269-sec-0099">Appendix 5</a>), ISI Web of Science (1987 to 9 October 2014; see <a href="./appendices#CD010269-sec-0100">Appendix 6</a>), Chinese Biological Medical Database (CBM, 1978 to 9 October 2014; see <a href="./appendices#CD010269-sec-0101">Appendix 7</a>) and China National Knowledge Infrastructure (CNKI, 1979 to 9 October 2014; see <a href="./appendices#CD010269-sec-0102">Appendix 8</a>) for relevant studies. </p> <p>We imposed no language and publication status restrictions. However, we excluded studies without detailed methodological information. Detailed methodological information means that the information obtained from full copies, abstracts or study authors should be sufficient to enable us to make judgements on the overall study quality. </p> </section> <section id="CD010269-sec-0053"> <h4 class="title">Searching other resources</h4> <p>We searched for unpublished or ongoing trials on the World Health Organization international clinical trials registry platform WHO ICTRP (<a href="http://www.who.int/ictrp/search/en/" target="_blank">www.who.int/ictrp/search/en/</a>), Current Controlled Trials metaRegister of controlled trials (<a href="http://www.isrctn.com/page/mrct" target="_blank">www.isrctn.com/page/mrct</a>) active registers, and the <a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a> database. </p> <p>We also searched the conference proceedings citation index.</p> <p>We handsearched the reference lists of included studies and previously published meta‐analyses and systematic reviews for relevant studies (<a href="./references#CD010269-bbs2-0099" title="LinYY , HeB , ChenJ , WangZN . Can dexmedetomidine be a safe and efficacious sedative agent in post‐cardiac surgery patients? A meta‐analysis. Critical Care2012;16(5):R169. [PUBMED: 23016926] ">Lin 2012</a>; <a href="./references#CD010269-bbs2-0122" title="TanJA , HoKM . Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta‐analysis. Intensive Care Medicine2010;36(6):926‐39. [PUBMED: 20376429] ">Tan 2010</a>; <a href="./references#CD010269-bbs2-0135" title="XiaZQ , ChenSQ , YaoX , XieCB , WenSH , LiuKX . Clinical benefits of dexmedetomidine versus propofol in adult intensive care unit patients: a meta‐analysis of randomized clinical trials. Journal of Surgical Research2013;185(2):833‐43. [PUBMED: 23910886] ">Xia 2013</a>; <a href="./references#CD010269-bbs2-0136" title="ZhuoS , ZhengJ , LluB . Sedative effect of dexmedetomidine versus propofol on postoperative patients in ICU: a systematic review. Chinese Journal of Evidence‐Based Medicine2012;12(6):686‐93. [EMBASE: 2012409765] ">Zhuo 2012</a>). We contacted the first author and the corresponding author of the included studies for information on other published and unpublished studies. </p> </section> </section> <section id="CD010269-sec-0054"> <h3 class="title" id="CD010269-sec-0054">Data collection and analysis</h3> <section id="CD010269-sec-0055"> <h4 class="title">Selection of studies</h4> <p>Two review authors (KC and YCX) independently scanned each title and abstract retrieved by the search strategy. We excluded irrelevant studies in this step. We excluded studies in abstract only and where no detailed methodological information could be obtained from the study authors. We obtained full copies of the remaining studies for further assessment. Our methodologist (YIC) resolved any disagreements unresolved by consensus. We used Endnote X7 to manage the search results and the articles. We noted the reasons for exclusion in Endnote X7. We were not blinded to the study authors, institutions or journals. </p> </section> <section id="CD010269-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (KC and YCX) independently extracted data from the articles using a modified version of the Cochrane Anaesthesia Review Group's (CARG) data extraction form (<a href="./appendices#CD010269-sec-0103">Appendix 9</a>). We selected three articles randomly to test our form before formal extraction. We exported data from these articles to <a href="http://doc.google.com" target="_blank">doc.google.com</a>. Our statistician (YC) resolved inconsistent data extraction between the two review authors. </p> </section> <section id="CD010269-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (KC and YCX) independently assessed the risk of bias using the Cochrane Collaboration’s tool (<a href="./references#CD010269-bbs2-0089" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>) in the following seven key domains: </p> <p> <ol id="CD010269-list-0004"> <li> <p>Random sequence generation;</p> </li> <li> <p>Allocation concealment;</p> </li> <li> <p>Blinding of participants and personnel;</p> </li> <li> <p>Blinding of outcome assessment;</p> </li> <li> <p>Incomplete outcome data;</p> </li> <li> <p>Selective reporting;</p> </li> <li> <p>Other bias (whether the groups were balanced at baseline, whether the co‐interventions were similar, etc.). </p> </li> </ol> </p> <p>We assessed blinding for each outcome as recommended. We judged each domain as 'low risk', 'high risk' or 'unclear risk'. We noted the summary of known facts and the source of this information for each domain. We asked the authors of the study for clarification if any details were unclear. </p> <p>We tested the 'Risk of bias' assessment tool on some similar studies. When KC and YCX disagreed, we consulted our methodologist (YIC) and content specialists (SMP and ZJL). After reaching consensus, we classified each included study into one of three categories, as follows. </p> <p> <ol id="CD010269-list-0005"> <li> <p>Low risk of bias: low risk of bias for all key domains.</p> </li> <li> <p>Unclear risk of bias: unclear risk of bias for one or more key domains.</p> </li> <li> <p>High risk of bias: high risk of bias for one or more key domains.</p> </li> </ol> </p> <p>We generated a 'Risk of bias' graph and a 'Risk of bias' summary. We also reported the risk of selective outcome reporting in the Results section under <a href="#CD010269-sec-0057">Assessment of risk of bias in included studies</a>. </p> <p>We performed the kappa test to evaluate the interobserver reliability between two review authors (KC and YCX). </p> </section> <section id="CD010269-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated the geometric mean difference (GMD) for continuous outcomes and the risk ratio (RR) for dichotomous outcomes. We describe the effects by their values and 95% confidence intervals (CIs). We considered two‐sided P &lt; 0.05 to be statistically significant. </p> </section> <section id="CD010269-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <p>We expected all the trials to be simple parallel‐group designs. The unit of analysis was a single measurement for each outcome from each participant. </p> </section> <section id="CD010269-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>We tried to contact the study authors for missing data and further information twice by e‐mail. For those missing data that could not be obtained from authors, we did the following: </p> <p> <ol id="CD010269-list-0006"> <li> <p>If we judged missing data to be 'missing at random', we only analysed the available data. We categorized the data as 'missing at random' if the loss was unrelated to the actual values of the missing data (<a href="./references#CD010269-bbs2-0088" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboratio, 2011. available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). For example, if participants died before receiving any study drugs. </p> </li> <li> <p>If we judged missing data to be 'not missing at random' and meta‐analysis was not feasible, we performed a qualitative synthesis. </p> </li> <li> <p>If we could systematically meta‐analyse missing data, we imputed average measurements for continuous outcomes and we inferred bad outcomes for categorical outcomes. </p> </li> </ol> </p> </section> <section id="CD010269-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>We measured heterogeneity using both the Chi² statistic and the I² statistic. Values for I² of 25%, 50% and 75% corresponded to low, moderate and high degrees of heterogeneity, respectively (<a href="./references#CD010269-bbs2-0086" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [PUBMED: 12958120] ">Higgins 2003</a>). We considered there to be substantial heterogeneity when a P value of Chi² &lt; 0.10 or I² &gt; 50%, or both (moderate and high degrees of heterogeneity). If we identified substantial heterogeneity, we checked the data entered into Review Manager 5 (<a href="./references#CD010269-bbs2-0114" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 5.3</a>). If I² exceeded 75%, we did not perform meta‐analyses. </p> </section> <section id="CD010269-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>We had planned to generate funnel plots if there were more than 10 studies included in the meta‐analyses of primary outcomes (<a href="./references#CD010269-bbs2-0088" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboratio, 2011. available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). For continuous outcomes, we would have conducted the Egger test to assess funnel plot asymmetry; for dichotomous outcomes, we would have conducted the arcsine test (<a href="./references#CD010269-bbs2-0120" title="SterneJA , SuttonAJ , IoannidisJP , TerrinN , JonesDR , LauJ , et al. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials. BMJ2011;343:d4002. [PUBMED: 21784880] ">Sterne 2011</a>). We would have performed all tests using STATA/SE 12.0. </p> </section> <section id="CD010269-sec-0063"> <h4 class="title">Data synthesis</h4> <p>We performed meta‐analyses only if we could include more than three studies. Otherwise, we undertook a qualitative synthesis. We selected a random‐effects model due to expected clinical heterogeneity. We used the Mantel‐Haenszel method to estimate dichotomous outcomes and the inverse variance method to estimate continuous outcomes. We did not perform a meta‐analysis for 'Proportion of sedation time spent at target sedation level' because there was no consistent outcome measure and statistical methods for pooling such percentage rates are not well developed (<a href="./references#CD010269-bbs2-0088" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboratio, 2011. available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). We would have synthesized the data of adult studies and paediatric studies separately if both data were available. We performed all statistical analyses using Review Manager 5 software (<a href="./references#CD010269-bbs2-0114" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 5.3</a>). </p> <p>The data for the durations of mechanical ventilation, weaning and ICU LOS are always skewed. We performed meta‐analyses on log‐transformed data. If we could obtain means and standard deviations of raw data without log‐transformation, we conducted a transformation using Method 1 mentioned in <a href="./references#CD010269-bbs2-0087" title="HigginsJP , WhiteIR , Anzures‐CabreraJ . Meta‐analysis of skewed data: combining results reported on log‐transformed or raw scales. Statistics in Medicine2008;27(29):6072‐92. [PUBMED: 18800342] ">Higgins 2008</a>. If means and standard deviations of raw data were not available, we estimated log‐transformed means using log‐transformed medians (<a href="./references#CD010269-bbs2-0090" title="HozoSP , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. [PUBMED: 15840177] ">Hozo 2005</a>) and calculated approximate standard deviations by dividing the log‐transformed interquartile range (log‐transformed third quartile minus first quartile) by 1.35 (<a href="./references#CD010269-bbs2-0089" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>). </p> <p>We did not make any assumptions about the distribution of censored data from time‐to‐event data (duration of mechanical ventilation and ICU LOS). Some of the studies analysed time‐to‐event data using, for instance, Cox's proportional‐hazards regression model and Kaplan‐Meier survival analyses. We undertook a narrative synthesis for these adjusted outcomes. </p> </section> <section id="CD010269-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If there were adequate data we performed subgroup analyses as follows.</p> <section id="CD010269-sec-0065"> <h5 class="title">For duration of mechanical ventilation and duration of weaning</h5> <p> <ol id="CD010269-list-0007"> <li> <p>Dexmedetomidine compared with clonidine.</p> </li> <li> <p>Class of alternative agents, classified according to the '<a href="./references#CD010269-bbs2-0060" title="Anatomical Therapeutic Chemical Classification System. WHO collaborating centre for drugs statistics methodology. International language for drug utilization research. www.whocc.no/ (Accessed 31st October 2012). ">Anatomical Therapeutic Chemical</a>' (ATC) classification system advocated by the World Health Organization’s collaborating centre for drugs statistics methodology. </p> </li> <li> <p>Sedation with or without analgesics/pain control.</p> </li> </ol> </p> </section> <section id="CD010269-sec-0066"> <h5 class="title">For risk of delirium</h5> <p> <ol id="CD010269-list-0008"> <li> <p>Different delirium scores used.</p> </li> <li> <p>Class of alternative agents.</p> </li> </ol> </p> </section> <section id="CD010269-sec-0067"> <h5 class="title">For risk of coma and adverse events</h5> <p> <ol id="CD010269-list-0009"> <li> <p>Class of alternative agents.</p> </li> <li> <p>Dexmedetomidine compared with clonidine.</p> </li> <li> <p>Rapid‐dosing regimens compared with slow‐dosing regimens, where rapid‐dosing regimens include intravenous bolus and continuous intravenous infusion with initial loading infusion, and where slow‐dosing regimens include continuous intravenous infusion without initial loading infusion and oral or nasogastric administration. </p> </li> </ol> </p> </section> <section id="CD010269-sec-0068"> <h5 class="title">For ICU LOS and mortality</h5> <p> <ol id="CD010269-list-0010"> <li> <p>Class of alternative agents.</p> </li> <li> <p>Dexmedetomidine compared with clonidine.</p> </li> <li> <p>Type of ICU (e.g. mixed ICU, medical ICU, surgical ICU, coronary care unit (CCU), respiratory care unit, burn unit). </p> </li> </ol> </p> <p>We determined whether there were differences of effect size among subgroups based on the P values from tests for subgroup differences (<a href="./references#CD010269-bbs2-0088" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboratio, 2011. available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). If differences existed, we compared the direction and magnitude of effect size in these subgroups with each other. </p> <p>If there were adequate data, we performed random‐effects meta‐regression to investigate how mean ventilation time (log‐transformed) of the included studies was associated with the risk of delirium (<a href="./references#CD010269-bbs2-0126" title="ThompsonSG , HigginsJP . How should meta‐regression analyses be undertaken and interpreted?. Statistics in Medicine2002;21(11):1559‐73. [PUBMED: 12111920] ">Thompson 2002</a>). We performed meta‐regression using R 3.0.2 with 'Metafor' package (version 1.9‐2). We used a restricted maximum‐likelihood estimator method to calculate the amount of heterogeneity (<a href="./references#CD010269-bbs2-0129" title="ViechtbauerW . Conducting meta‐analyses in R with the metafor package.. Journal of Statistical Software2010;36(3):1‐48. ">Viechtbauer 2010</a>). We determined whether this difference was statistically significant based on the P value of the coefficients. </p> </section> </section> <section id="CD010269-sec-0069"> <h4 class="title">Sensitivity analysis</h4> <p>If there were sufficient studies, we undertook sensitivity analyses by excluding studies as follows: </p> <p> <ol id="CD010269-list-0011"> <li> <p>Studies at high or unclear risk of bias;</p> </li> <li> <p>Studies of a non‐standardized design: RCTs without a target sedation level or using non‐intravenous administration. </p> </li> </ol> </p> <p>We also undertook sensitivity analyses by pooling observed data only, without any imputation. </p> <section id="CD010269-sec-0070"> <h5 class="title">Summary of findings</h5> <p>We used the principles of the GRADE system (<a href="./references#CD010269-bbs2-0082" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians?. BMJ2008;336(7651):995‐8. [PUBMED: 18456631] '>Guyatt 2008</a>) to assess the quality of the body of evidence associated with specific outcomes: duration of mechanical ventilation, rate of delirium, rate of coma, rate of bradycardia, duration of weaning, ICU length of stay and mortality. We constructed a 'Summary of findings' table using GRADE software. The GRADE approach appraised the quality of a body of evidence based on the extent to which one can be confident that an estimate of effect or association reflects the item being assessed. The quality of a body of evidence is derived from within‐study risk of bias (methodological quality), the directness of the evidence, heterogeneity of the data, precision of effect estimates, and risk of publication bias. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010269-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010269-sec-0071"></div> <section id="CD010269-sec-0072"> <h3 class="title">Description of studies</h3> <section id="CD010269-sec-0073"> <h4 class="title">Results of the search</h4> <p>Running the search strategy of electronic databases yielded 3009 citations: 1348 citations from western databases and 1661 citations from Chinese databases. We excluded 2956 citations based on abstract content alone. Three citations were in abstract only, and we failed to retrieve further information or to trace the original investigators. We performed full‐text review of 53 citations, and finally included six citations in our data synthesis (and one citation in <a href="./references#CD010269-bbs1-0003" title="">Studies awaiting classification</a>). One included citation reported on two independently‐conducted multi‐centre, randomized, double‐blind studies, the MIDEX trial (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a> Identifier: NCT00481312) and the PRODEX trial (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a> Identifier: NCT00479661). We considered them as two discrete studies during data synthesis (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>: MIDEX trial; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>: PRODEX trial). We found two potentially relevant unpublished/ongoing studies from clinical trial registries and emailed the contact investigators (<a href="./references#CD010269-bbs2-0055" title="NCT01059929 . Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU). clinicaltrials.gov/ct2/show/NCT01059929 accessed 10 December 2014. ">NCT01059929</a>; <a href="./references#CD010269-bbs2-0056" title="NCT01760967 . Dexmedetomidine for Sepsis in ICU Randomized Evaluation Trial (DESIRE). clinicaltrials.gov/ct2/show/NCT01760967 accessed 10 December 2014. ">NCT01760967</a>). One replied (<a href="./references#CD010269-bbs2-0056" title="NCT01760967 . Dexmedetomidine for Sepsis in ICU Randomized Evaluation Trial (DESIRE). clinicaltrials.gov/ct2/show/NCT01760967 accessed 10 December 2014. ">NCT01760967</a>), but provided no useful information (<a href="./references#CD010269-sec-0137" title="">Characteristics of ongoing studies</a> table shows detailed information about the ongoing studies). We did not obtain any information about unpublished or ongoing randomized controlled trials (RCTs) from authors of the included studies. <a href="#CD010269-fig-0001">Figure 1</a> presents the entire study selection process. </p> <div class="figure" id="CD010269-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Selection process for studies included in data synthesis." data-id="CD010269-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Selection process for studies included in data synthesis.</p> </div> </div> </div> </section> <section id="CD010269-sec-0074"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD010269-sec-0134" title="">Characteristics of included studies</a>. </p> <p>We include seven studies in our review. Six studies were of a two‐arm design. One used a four‐arm design that compared dexmedetomidine infusion alone, midazolam infusion alone, dexmedetomidine infusion combined with midazolam infusion and dexmedetomidine infusion combined with midazolam bolus (<a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). We extracted the data only from the dexmedetomidine‐infusion‐alone group and the midazolam‐infusion‐alone group. Five of the included studies were international multi‐centre (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>); one was multi‐centre, conducted in the United States (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>); and one was single‐centre, conducted in China (<a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). Six studies received funding support from pharmaceutical firms which manufacture dexmedetomidine (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>), and one did not state any potential conflict of interest (<a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). </p> <p><b>Types of participants</b> </p> <p>There were 1624 participants meeting the inclusion criteria. The sample sizes of studies ranged from 37 to 501. All the studies recruited adults from mixed intensive care units (ICUs) which may include medical, surgical and trauma patients. All the studies required participants to have an anticipated need for sedation of at least 24 to 36 hours. The main exclusion criteria of the studies include conditions as follows: neurological disease, severe bradycardia, second or third degree atrioventricular conduction block, hepatic impairment and pregnancy. </p> <p><b>Types of interventions</b> </p> <p>We found no eligible studies for clonidine. All the included studies compared dexmedetomidine with traditional sedatives. The traditional sedatives could be midazolam (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>), lorazepam (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>), propofol (<a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>), or standard care (either propofol or midazolam) (<a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>). A total of 871 participants (53.6%) received dexmedetomidine, 393 (24.2%) midazolam, 51 (3.1%) lorazepam, 249 (15.3%) propofol or 60 (3.7%) standard care. All studies administered sedative agents intravenously. The infusion rate of dexmedetomidine varied among trials, ranging from 0.15 to 1.5 mcg/kg per hour. Only one study routinely administered loading doses of dexmedetomidine (<a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). </p> <p>Only four studies explicitly stated that participants might receive sedation prior to the study treatment (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>): three reported that the sedation scores at the time of study treatment initiation were similar between groups (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>), and one started treatment only when the participants were within a prespecified range of sedation score (<a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>). Other studies reported no detailed information about sedation prior to the study treatment (<a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>; <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). All the studies stated that they titrated sedatives to a target sedation level: <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> and <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> set the target as a Richmond Agitation‐Sedation Scale (RASS) score of 0 to ‐3 and assessed it every two hours; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a> set it as a "clinically individualized target" based on RASS and assessed it twice daily; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> set it as a RASS score of ‐2 to 1 and assessed it every four hours; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> set it as a RASS score of ‐4 to 0 and assessed it every four hours; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a> set it as a RASS score of ‐2 to 1 and assessed it every four hours; <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a> set it as a Motor Activity Assessment Scale (MAAS) score of 3 and assessed it every two hours. Three studies performed daily interruption as part of the study protocol (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>). Six studies routinely gave opioids to treat pain during sedation (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>) and one study did not report that they used analgesics (<a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). Two studies used intravenous haloperidol to control delirium (<a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>), and the others did not report any information about delirium treatment. Four studies stopped sedation after extubation (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>); two studies stopped it when the investigators thought it was no longer required (<a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>); one study did not explicitly state the indication for sedation discontinuation (<a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). </p> <p><b>Types of outcome measures</b> </p> <p>Five studies reported on duration of mechanical ventilation (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>). All the studies reported on the risk of delirium, based on the confusion assessment method for the intensive care unit (CAM‐ICU). Three studies explicitly described the frequency of delirium assessment: <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> assessed it daily during sedation interruption; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> assessed it daily; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a> assessed it when the RASS score was more than ‐3. Only two studies explicitly described the follow‐up period of delirium assessment: <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a> assessed it until hospital discharge or for 12 days; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> assessed it during study treatment. One study reported on the risk of coma (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>). The investigators defined coma as a RASS score of ‐4 or ‐5 and assessed it until hospital discharge or for 12 days. </p> </section> <section id="CD010269-sec-0075"> <h4 class="title">Excluded studies</h4> <p>Of the 46 studies excluded during full‐text review, 44 were because they did not explicitly report the required or anticipated duration of sedation or did not meet the criteria, one because it was not an RCT and one because not all the participants were mechanically ventilated. The <a href="./references#CD010269-sec-0135" title="">Characteristics of excluded studies</a> table provides detailed reasons for the exclusions. </p> </section> </section> <section id="CD010269-sec-0076"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD010269-sec-0077"> <h4 class="title">Allocation</h4> <p>Five studies had adequate sequence generation (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>). Two studies reported they used stratified randomization, but did not state in detail how they randomized the participants (<a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). We contacted the authors of <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> and <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a> for additional methodological information, but no‐one replied. We therefore judged them to be at 'unclear risk of bias for random sequence generation. Five studies had adequate allocation concealment (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>). Two studies did not state that they concealed the randomization sequence (<a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>), and we therefore judged them to be at 'high' risk of bias for allocation concealment. The two review authors were in complete agreement for this domain. </p> <p><a href="#CD010269-fig-0002">Figure 2</a> and <a href="#CD010269-fig-0003">Figure 3</a> illustrate the proportion of studies with those judgements and the judgement made for each study. See the <a href="./references#CD010269-sec-0134" title="">Characteristics of included studies</a> for details of those judgements. . </p> <div class="figure" id="CD010269-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010269-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010269-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010269-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD010269-sec-0078"> <h4 class="title">Blinding</h4> <p>Four studies used an adequate double‐blinded design and described the details of the blinding method (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>). One study used a double‐dummy design, but the blinding method was brittle and we believe that the study investigators could easily have broken the blinding (<a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>). One study did not mention that the participants or the investigators were blinded, and therefore probably did not perform blinding (<a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). One study stated that they were "unblinded" (<a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>). We believed blinding had little impact on these objective outcomes, and we therefore judged <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>, <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a> and <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a> to be at 'low' risk for blinding of outcome assessment in objective outcomes, but at 'high' risk for blinding of participants and personnel and blinding of outcome assessment in subjective outcomes. Agreement between the two review authors for blinding of participants and personnel was at 86% (kappa = 0.70). The two review authors were in complete agreement for blinding of outcome assessment, both subjective and objective outcomes. </p> <p>Figure 2 and Figure 3 illustrate the proportion of studies with those judgements and the judgement made for each study. <a href="./references#CD010269-sec-0134" title="">Characteristics of included studies</a> showed the details for the judgements. </p> </section> <section id="CD010269-sec-0079"> <h4 class="title">Incomplete outcome data</h4> <p>Five studies had low withdrawal rates, and reasons for withdrawal were explicitly reported and balanced across groups (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>; <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). However, in <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> and <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>, withdrawal due to lack of efficacy was significantly more frequent in dexmedetomidine participants and would therefore inevitably bias the results. We judged them to be at 'high' risk of bias. The two review authors were in complete agreement on this domain. </p> <p>Figure 2 and Figure 3 illustrate the proportion of studies with those judgements and the judgement made for each study. <a href="./references#CD010269-sec-0134" title="">Characteristics of included studies</a> showed the details for the judgements. </p> </section> <section id="CD010269-sec-0080"> <h4 class="title">Selective reporting</h4> <p>There was no indications of selective reporting in any of the included studies. The two review authors were in complete agreement for this domain. </p> </section> <section id="CD010269-sec-0081"> <h4 class="title">Other potential sources of bias</h4> <p>Six studies appeared to be free of other sources of bias (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>; <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). One study used continuous infusion of lorazepam as a comparison intervention (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>). Because of the long half‐life of lorazepam, such a study design might increase the risk of coma in the control group, and we suspected it to be a potential source of bias. Agreement between the two review authors for other potential sources of bias was at 86% (kappa = 0.70). </p> <p>Figure 2 and Figure 3 illustrate the proportion of studies with those judgements and the judgement made for each study. <a href="./references#CD010269-sec-0134" title="">Characteristics of included studies</a> showed the details for the judgements. </p> </section> </section> <section id="CD010269-sec-0082"> <h3 class="title" id="CD010269-sec-0082">Effects of interventions</h3> <p>See: <a href="./full#CD010269-tbl-0001"><b>Summary of findings for the main comparison</b> Dexmedetomidine compared to traditional sedative agents for long‐term sedation during mechanical ventilation in critically ill patients</a> </p> <p><b>Duration of mechanical ventilation</b> (<a href="./references#CD010269-fig-0004" title="">Analysis 1.1</a>; <a href="./references#CD010269-fig-0005" title="">Analysis 1.2</a>) </p> <p>Four studies (1448 participants) compared the duration of mechanical ventilation (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>), and showed the median time of ventilation in the dexmedetomidine group was less than control. <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>, <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> and <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> analysed the data using Cox’s proportional‐hazards regression and <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> analysed it using Kaplan‐Meier survival analysis. Three of them were statistically significant (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>), but one was not (<a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>) (calculations from median/interquartile range to geometric mean/standard deviation (SD) are shown in <a href="#CD010269-tbl-0002">Table 1</a>). <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> reported the median but no interquartile range. We were unable to obtain the raw data, and thus could not estimate the standard deviation and add the data into our meta‐analysis. We obtained data for <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a> from the authors and pooled it with the other three studies (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>). Meta‐analysis of 1119 participants yielded a random‐effects estimate of the geometric mean difference (MD) of ‐0.25 log hours (95% confidence interval (CI) ‐0.40 to ‐0.10, P = 0.001), corresponding to a reduction of 22% in the geometric mean (95% CI 10% to 33%). Neither the I² nor the Chi² statistics indicated evidence of statistical heterogeneity across the trials, (I² = 0%; Chi² = 0.42, P = 0.94). </p> <div class="table" id="CD010269-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Calculation from median/interquartile range to geometric mean/standard deviation (SD)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Median</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interquartile range</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Geometric mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Geometric SD</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Duration of mechanical ventilation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>123 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67 ‐ 337 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.812</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.197</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>164 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92 ‐ 380 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.051</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Duration of mechanical ventilation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45 ‐ 257 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.291</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>118 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 ‐ 327 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.771</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.421</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Duration of mechanical ventilation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.2 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.5 – 338.8 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.195</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110.6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.1 – 675.0 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.603</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>ICU LOS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8 days (211 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8 ‐ 34.6 days (115 ‐ 831 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.465</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.1 days (243 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8 ‐ 26.2 days (140 ‐ 630 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.114</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>ICU LOS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8 days (164 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8 ‐ 20.0 days (90 ‐ 480 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.922</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7 days (185 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.9 ‐ 21.7 days (93 ‐ 520 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.275</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>ICU LOS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 ‐ 19 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.989</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 ‐ 15 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.679</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>ICU LOS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7 – 19.5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.705</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.807</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7 – 29.0 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.101</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ICU: intensive care unit<br/> LOS: length of stay </p> </div> </div> <p>We performed subgroup analysis for different classes of alternatives. The subgroups were small, with one or two studies in each. The results from all subgroups favoured dexmedetomidine, and we detected no significant difference between them (P = 0.84). We did not perform subgroup analyses for dexmedetomidine compared with clonidine or sedation with or without pain control, because of inadequate data. </p> <p><a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> and <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> reported not only 'duration of mechanical ventilation', which included non‐invasive ventilation time, but also 'time to extubation' which also matched our definition. We performed a post hoc sensitivity analysis to assess how the result would be changed if we extracted the data from 'time to extubation' instead of 'duration of mechanical ventilation'. The sensitivity analysis yielded a geometric mean difference of ‐0.34 log hours (95% CI ‐0.49 to ‐0.20, P &lt; 0.00001), corresponding to a reduction of 29% in the geometric mean (95% CI 18% to 39%). We did not undertake sensitivity analyses by excluding studies at high risk of bias or studies with non‐standardized design because of the small number of studies. </p> <p>We were not able to conduct the Egger test because of the small number of studies, but we suspected reporting bias for this outcome, because these four studies received funding support from pharmaceutical firms which manufacture dexmedetomidine. </p> <p><b>Risk of delirium</b> (<a href="./references#CD010269-fig-0006" title="">Analysis 1.3</a>; <a href="./references#CD010269-fig-0007" title="">Analysis 1.4</a>) </p> <p>The data for meta‐analysis were available from all the studies, with 1624 participants (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>; <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). The risk of delirium was numerically lower in the dexmedetomidine group than in the control group (risk ratio (RR) 0.85; 95% CI 0.63 to 1.14), but was not statistically significant (P = 0.27). The heterogeneity was high across the trials (I² = 70%). </p> <p>We performed subgroup analyses for different classes of alternative agents. The number of studies within subgroups ranged from one to four, and the difference in effect size was significant among subgroups (P = 0.02). Pooled results from subgroups showed the risk of delirium was lower in participants with dexmedetomidine than in those with benzodiazepine derivatives (RR 0.81; 95% CI 0.59 to 1.09; 1007 participants) or propofol (RR 0.37; 95% CI 0.16 to 0.87; 495 participants), but higher than in participants with standard care (RR 1.44; 95% CI 0.86 to 2.41; 122 participants). There was a high level of heterogeneity in the subgroup of benzodiazepine derivatives (I² = 72%), but a low level in the subgroup of standard care (I² = 6%). Because all the studies assessed delirium based on the confusion assessment method for the intensive care unit (CAM‐ICU), subgroup analyses for different delirium scores were not possible. </p> <p>We performed meta‐regression on log‐transformed mean ventilation time using data from six studies (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>) (<a href="#CD010269-tbl-0003">Table 2</a>). The meta‐regression did not show that the log‐transformed mean ventilation time was associated with the risk of delirium (P = 0.94) and was unable to explain the heterogeneity (R² = 0.00%). </p> <div class="table" id="CD010269-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Meta‐regression for incidence of delirium on geometric mean ventilation time</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>tau²</b> (estimated amount of residual heterogeneity) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1460 (SE = 0.1596)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>tau</b> (square root of estimated tau² value) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3820</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>I²</b> (residual heterogeneity / unaccounted variability) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.09%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>H²</b> (unaccounted variability / sampling variability) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>R²</b> (amount of heterogeneity accounted for) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.00%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intercept</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0895 (95% CI ‐5.4218 to 5.6007, P = 0.9746)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Coefficient for log‐transformed mean ventilation time</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.0442 (95% CI ‐1.1989 to 1.1105, P = 0.9403)</p> </td> </tr> </tbody> </table> </div> <p>We undertook a sensitivity analysis by pooling observed data without any imputation, and confirmed a nearly identical result (RR 0.84; 95% CI 0.63 to 1.14, P = 0.27). We did not undertake sensitivity analyses by excluding studies at high risk of bias or studies with non‐standardized design, due to the small number of studies. </p> <p>Two studies also reported on the number of delirium‐free days during study treatment (<a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>) or a 12‐day period (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>). <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> showed participants treated with dexmedetomidine had more delirium‐free days than those treated with midazolam (2.5 days vs 1.7 days, P = 0.02), but <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a> did not (dexmedetomidine: 9 days, lorazepam: 7 days, P = 0.09). </p> <p>We were not able to conduct the arcsine test because of the small number of studies, but we suspected reporting bias for this outcome because six studies received funding support from pharmaceutical firms which manufacture dexmedetomidine (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>). </p> <p><b>Risk of coma</b> </p> <p>Because only one study investigated the risk of coma (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; 103 participants), meta‐analysis was impossible. In <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>, the risk of coma was 63% in the dexmedetomidine group and 92% in the lorazepam group (P &lt; 0.001). Participants with dexmedetomidine also had more coma‐free days than those in the lorazepam group (10 days vs 8 days, P &lt; 0.001). </p> <p>We were not able to conduct the arcsine test, but we suspected reporting bias for this outcome because <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a> received funding support from pharmaceutical firms which manufacture dexmedetomidine. </p> <p><b>Adverse events</b> </p> <p>Incidence of bradycardia (<a href="./references#CD010269-fig-0008" title="">Analysis 1.5</a>; <a href="./references#CD010269-fig-0009" title="">Analysis 1.6</a>; <a href="./references#CD010269-fig-0010" title="">Analysis 1.7</a>) </p> <p>Six studies, covering 1587 participants, reported on the incidence of bradycardia (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). Compared with traditional sedatives, those participants allocated to dexmedetomidine had a 111% significantly higher incidence of bradycardia (RR 2.11; 95% CI 1.39 to 3.20, P = 0.0004). The statistical heterogeneity was moderate across the trials (Chi² = 8.28, P = 0.14; I² = 40%). </p> <p>We conducted two subgroup analyses, one for the class of alternative agents and one for the dosing regimens: </p> <p>For subgroup analyses of different classes of alternative agents, the difference in effect size was significant (P = 0.04). Although all the pooled results from subgroups showed a higher incidence associated with dexmedetomidine, the standard care group had the highest risk ratio (RR 7.50; 95% CI 0.40 to 140.91; 85 participants) and the propofol group had the lowest (RR 1.20; 95% CI 0.74 to 1.94; 495 participants). </p> <p>For subgroup analyses of different dosing regimens (rapid or slow), no between‐groups difference was detected (P = 0.32). </p> <p>We undertook a sensitivity analysis by pooling the observed data without any imputation, and confirmed almost the same result (RR 2.11; 95% CI 1.39 to 3.21). We did not undertake sensitivity analyses by excluding studies at high risk of bias or studies with non‐standardized designs, due to the small number of studies. </p> <p>Incidence of hypotension (<a href="./references#CD010269-fig-0011" title="">Analysis 1.8</a>; <a href="./references#CD010269-fig-0012" title="">Analysis 1.9</a>) </p> <p>Six studies, covering 1587 participants, reported on the incidence of hypotension (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>). The risk of hypotension was higher with dexmedetomidine, but this difference was not statistically significant (RR 1.22; 95% CI 0.86 to 1.74, P = 0.26). The level of heterogeneity was high (I² = 53%, P = 0.07). </p> <p>We conducted two subgroup analyses, one for the class of alternative agents and one for the dosing regimens, but none of them indicated differences in effect size between subgroups (class of alternative agents, P = 0.57; dosing regimens, P = 0.17). </p> <p>We undertook a sensitivity analysis by pooling the observed data without any imputation, and confirmed almost the same result (RR 1.22; 95% CI 0.86 to 1.73, P = 0.27). We did not undertake sensitivity analyses by excluding trials at high risk of bias or trials with non‐standardized designs, due to the small number of trials. </p> <p>Incidence of hypertension </p> <p>Three trials, covering 1356 participants, reported on the incidence of hypertension (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>). None of the trials reported a difference between dexmedetomidine and alternatives: in <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>, the incidence of hypertension was 21.5% in the dexmedetomidine group and 20.8% in the midazolam group (P = 0.913). In <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>, the incidence of hypertension was 21.1% in the dexmedetomidine group and 15.0% in the propofol group (P = 0.08). In <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>, the incidence of hypertension was 18.9% in the dexmedetomidine group and 29.5% in the midazolam group (P = 0.91). </p> <p>Other adverse events possibly caused by alpha‐2 agonist </p> <p>We added other alpha‐2‐associated adverse events that were reported to be significant in at least one study. Other adverse events included tachycardia, first‐degree atrioventricular block, hyperglycaemia and hypoglycaemia. </p> <p>1. Tachycardia</p> <p><a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> reported tachycardia as a significant adverse event, and we therefore include it in our assessment. Four studies, covering 1462 participants, reported on the incidence of tachycardia (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>). One of them indicated that dexmedetomidine was more likely to induce tachycardia than propofol (19.5% vs 11.3%, respectively; P = 0.02) (<a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>). Two studies showed that participants allocated to dexmedetomidine compared with midazolam had a statistically significantly lower risk of tachycardia (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>: dexmedetomidine 13.8%, midazolam 21.6%, P = 0.025; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>: dexmedetomidine 25.4%, midazolam 44.3%, P &lt; 0.001), but one study comparing dexmedetomidine with lorazepam did not find a significant difference (dexmedetomidine 69%, lorazepam 73%, P = 0.71) (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>). When we tried to pool these data, we detected an extremely high level of statistical heterogeneity (I² = 84%), and therefore abandoned the analysis. </p> <p>2. First‐degree atrioventricular block</p> <p><a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> reported first‐degree atrioventricular block as a significant adverse event. Two studies, covering 993 participants, reported on the incidence of first‐degree atrioventricular block (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>). In <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>, the incidence was significantly higher in the dexmedetomidine group than in the propofol group (0.8% vs 3.7%, respectively; P = 0.04), but in <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>, comparing dexmedetomidine with midazolam (1.2% in each group; P = 0.99), we did not find any difference. </p> <p>3. Hyperglycaemia</p> <p><a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> reported hyperglycaemia as a significant adverse event. Three studies, totaling 1359 participants, reported on the incidence of hyperglycaemia (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>). Only in <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> was the incidence higher in the dexmedetomidine group than in the midazolam group (56.6% vs 42.6%, respectively; P = 0.02). In the other studies, the incidence was low or absent, and did not reach statistical significance (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>: 2% in dexmedetomidine group and 2% in midazolam group; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>: 0.8% in dexmedetomidine group and 0% in propofol group). </p> <p>4. Hypoglycaemia</p> <p><a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> reported hypoglycaemia as a significant adverse event. Two studies, covering 993 participants, reported on the incidence of hypoglycaemia (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>). <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>, comparing dexmedetomidine with midazolam, showed that the incidence in the dexmedetomidine group was higher (4% vs 0.8%, respectively; P = 0.02), while <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> compared dexmedetomidine with propofol, and showed the same incidence in both groups (1.2%; P = 0.99) </p> <p><b>Proportion of sedation time spent at target sedation level</b> (<a href="./references#CD010269-fig-0014" title="">Analysis 1.11</a>) </p> <p>All the studies evaluated the proportion of sedation time spent at target sedation level. <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a> reported that participants treated with dexmedetomidine spent a higher proportion of time at the target sedation level than did those treated with lorazepam. Both physicians and nurses assessed the sedation level in this study: the proportion assessed by nurses was 80% for the dexmedetomidine group and 67% for the lorazepam group (P = 0.04); the proportion assessed by physicians was 67% for the dexmedetomidine group and 55% for the lorazepam group (P = 0.008). Similarly, in <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>, there were more Richmond Agitation‐Sedation Scale (RASS) assessment scores in the target range in the dexmedetomidine group (66%) than in the standard sedation group (38%) during the first 48 hours of the trial (P = 0.01). The other five trials showed similar proportions of time between study groups: in <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>, 60.7% for the dexmedetomidine group and 56.6% for the midazolam group (P = 0.15); in <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>, 64.6% for the dexmedetomidine group and 64.7% for the propofol group (P = 0.97); in <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>, 77.3% for the dexmedetomidine group and 75.1% for the midazolam group (P = 0.18); in <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>, 64% for the dexmedetomidine group and 63% for the standard care group; in <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>, 52.8% for the dexmedetomidine group and 48.6% for the midazolam group. <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> also separately calculated the proportion of participants with a different sedation target: RASS ‐4 and RASS ‐3 to 0. Of those with RASS ‐4, participants on dexmedetomidine spent 42% of the time at the target level, compared with 62% for participants on standard care; of those with RASS ‐3 to 0, participants on dexmedetomidine spent 74% of the time at the target level, compared with 64% for participants on standard care. </p> <p><b>Duration of weaning</b> </p> <p>One study reported on the duration of weaning (<a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; 85 participants). The data for <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>, sourced from the electronic supplementary material which was available online, show that the median weaning times were 59.4 hours for the dexmedetomidine group (range 0 ‐ 259 hours) and 78.0 hours for the standard care group (either propofol or midazolam) (range 0 ‐ 565 hours), but the difference was not statistically significant (P = 0.270). </p> <p><b>Intensive care unit length of stay (ICU LOS)</b> (<a href="./references#CD010269-fig-0015" title="">Analysis 1.12</a>) </p> <p>Six trials, covering 1589 participants, compared intensive care unit (ICU) lengths of stay (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>). <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>, <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> and <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> analysed the data using Cox’s proportional‐hazards regression, <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> and <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a> analysed it using Kaplan‐Meier survival analysis and <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a> analysed it using Wilcoxon rank‐sum tests. All the studies showed that the median ICU length of stay was shorter in the dexmedetomidine groups than in the control groups, but none of the studies showed statistically significant results. Since <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> reported only the median without the interquartile range, we carried out meta‐analysis only on the other five trials (calculations from median/interquartile range to geometric mean/SD are shown in <a href="#CD010269-tbl-0002">Table 1</a>). Meta‐analysis yielded a random‐effects estimate of the geometric mean difference of ‐0.15 log days (95% CI ‐0.28 to ‐0.01, P = 0.04), a statistically significant finding corresponding to a reduction of 14% in the geometric mean (95% CI 1% to 24%). Neither the I² test (0%) nor the Chi² test (0.28, P = 0.99) indicate the presence of statistical heterogeneity. Subgroup analyses for different classes of alternative agents did not find any significant difference in effect size between subgroups (P = 0.93). We did not undertake sensitivity analyses by excluding studies at high risk of bias or studies with non‐standardized designs, due to the small number of studies. </p> <p><b>Mortality</b> (<a href="./references#CD010269-fig-0016" title="">Analysis 1.13</a>; <a href="./references#CD010269-fig-0017" title="">Analysis 1.14</a>) </p> <p>Six studies, covering 1584 participants, assessed mortality (<a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>; <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>). We did not observed a significant difference between the dexmedetomidine and traditional sedative agents (RR 0.99; 95% CI 0.79 to 1.24, P = 0.92). The level of heterogeneity was low (Chi² = 6.05, P = 0.30; I² = 17%). We undertook subgroup analyses of different classes of alternative agents and found no significant differences in effect size among subgroups (P = 0.42). A sensitivity analysis pooling observed data only, without any imputation, did not change the result (RR 0.99; 95% CI 0.78 to 1.24, P = 0.90) (<a href="./references#CD010269-fig-0017" title="">Analysis 1.14</a>). We did not undertake sensitivity analyses by excluding studies at high risk of bias or studies with non‐standardized designs, due to the small number of studies. </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010269-sec-0083" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010269-sec-0083"></div> <section id="CD010269-sec-0084"> <h3 class="title" id="CD010269-sec-0084">Summary of main results</h3> <p>In this systematic review, we assessed evidence from seven studies, involving 1624 critically ill participants, to investigate the effectiveness and safety of alpha‐2 agonists for long‐term sedation during mechanical ventilation. All the included studies investigated adults, and compared dexmedetomidine with traditional sedatives. Our meta‐analyses show that the use of dexmedetomidine in people who need more than 24 hours sedation was associated with a reduction of 22% in the geometric mean for ventilation time (95% confidence interval (CI) 10% to 33%). Because the relative change in geometric means usually produces results similar to the relative change in arithmetic means (<a href="./references#CD010269-bbs2-0077" title="FriedrichJO , AdhikariNK , BeyeneJ . Ratio of geometric means to analyze continuous outcomes in meta‐analysis: comparison to mean differences and ratio of arithmetic means using empiric data and simulation. Statistic in Medicine2012;31(17):1857‐86. [PUBMED: 22438170] ">Friedrich 2012</a>), dexmedetomidine could cut approximately one‐fifth of the ventilation time. Our meta‐analysis provides no clear evidence that dexmedetomidine could reduce the risk of delirium. We found only one study reporting the risk of coma, but some methodological flaws prevented us from drawing a robust conclusion (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>). </p> <p>The results of our meta‐analyses, along with subgroup analyses for different classes of alternatives, showed a consistent trend across all the studies indicating a reduction in ventilation time. Two studies, <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> and <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>, which contributed most weight to the meta‐analysis, assessed both invasive and noninvasive ventilation time, and thus offer a wider application for this outcome. As a likely consequence of less ventilation time, we also observed a 14% reduction in intensive care unit (ICU) length of stay. However, the reason for this effect was unclear. One potential explanation might be that dexmedetomidine could provide adequate pain control. Early studies in rats and healthy volunteers suggested that dexmedetomidine offered additive or synergist analgesic effects (<a href="./references#CD010269-bbs2-0083" title="HallJE , UhrichTD , BarneyJA , ArainSR , EbertTJ . Sedative, amnestic, and analgesic properties of small‐dose dexmedetomidine infusions. Anesthesia and Analgesia2000;90(3):699‐705. [PUBMED: 10702460] ">Hall 2000</a>; <a href="./references#CD010269-bbs2-0094" title="JaakolaML , SalonenM , LehtinenR , ScheininH . The analgesic action of dexmedetomidine‐‐a novel alpha 2‐adrenoceptor agonist‐‐in healthy volunteers. Pain1991 Sep;46(3):281‐5. [PUBMED: 1684653] ">Jaakola 1991</a>; <a href="./references#CD010269-bbs2-0105" title="MeertTF , DeKockM . Potentiation of the analgesic properties of fentanyl‐like opioids with alpha 2‐adrenoceptor agonists in rats. Anesthesiology1994 Sep;81(3):677‐88. [PUBMED: 7916547] ">Meert 1994</a>; <a href="./references#CD010269-bbs2-0125" title="ThamSM , AngusJA , TudorEM , WrightCE . Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2‐adrenoceptor agonists in acute pain models in mice. British Journal of Pharmacology2005 Mar;144(6):875‐84. [PUBMED: 15778704] ">Tham 2005</a>). Results from previous meta‐analyses on perioperative use of dexmedetomidine for postoperative pain also found that dexmedetomidine decreased pain intensity and opioid consumption (<a href="./references#CD010269-bbs2-0063" title="BlaudszunG , LysakowskiC , EliaN , TramèrMR . Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta‐analysis of randomized controlled trials. Anesthesiology2012 Jun;116(6):1312‐22. [PUBMED: 22546966] ">Blaudszun 2012</a>; <a href="./references#CD010269-bbs2-0116" title="SchnabelA , Meyer‐FrießemCH , ReichlSU , ZahnPK , Pogatzki‐ZahnEM . Is intraoperative dexmedetomidine a new option for postoperative pain treatment? A meta‐analysis of randomized controlled trials. Pain2013 Jul;154(7):1140‐9. [PUBMED: 23706726] ">Schnabel 2013</a>). The importance of analgesia in reducing ventilation time and hospital stay has been confirmed by other randomized controlled trials (RCTs) (<a href="./references#CD010269-bbs2-0065" title="BreenD , KarabinisA , MalbrainM , MoraisR , AlbrechtS , JarnvigIL , et al. Decreased duration of mechanical ventilation when comparing analgesia‐based sedation using remifentanil with standard hypnotic‐based sedation for up to 10 days in intensive care unit patients: a randomised trial. Critical Care2005;9(3):R200‐10. [PUBMED: 15987391] ">Breen 2005</a>; <a href="./references#CD010269-bbs2-0121" title="StromT , MartinussenT , ToftP . A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet2010;375(9713):475‐80. [PUBMED: 20116824] ">Strom 2010</a>). In our review, <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> compared the visual analogue scale (VAS) scores of nurses’ assessments in those patients who were able to communicate, and found that the mean VAS scores in the dexmedetomidine group were lower than in the standard care group (30.6 vs 47.5; P &lt; 0.001). Both <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> and <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> confirmed better pain scores in the dexmedetomidine group, although <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> showed no difference in the cumulative dose of fentanyl for pain control between both groups, probably because the dexmedetomidine participants might request more additional analgesics. In <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> and <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>, participants on dexmedetomidine were more able to communicate pain, more arousable and more co‐operative. This characteristic of dexmedetomidine might promote the rational use of opioids and facilitate the delivery of patient care and medical examination. Another candidate explanation was suggested by a subgroup analysis of <a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>. This post hoc analysis revealed that dexmedetomidine provided greater improvement in ventilation time among septic participants than among non‐septic participants, with the investigators attributing this effect to the anti‐inflammatory, organ‐protective and anti‐sympathetic properties of dexmedetomidine. </p> <p>We found no evidence for the risk of delirium, with a high level of statistical heterogeneity. Two studies compared the number of ICU days without delirium but demonstrated inconsistent results (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a>). Subgroup analysis of different classes of alternative agents found that both the benzodiazepine derivatives subgroup and the propofol subgroup favoured dexmedetomidine, while the standard care subgroup favoured the control condition. Because standard care participants used midazolam or propofol (both drugs were analysed alone in other subgroups), we were unable to attribute this difference to the characteristics of the control drugs. One possible explanation could be that in standard care both studies were at high risk for blinding of personnel and outcome assessment, which may have biased the results. Meta‐regression on geometric mean ventilation time found little statistical evidence to explain the heterogeneity, probably due to the small number of studies. We noted considerable variation among the studies for risk of delirium, which might be another important source of heterogeneity. There were several reasons for this: firstly, the time in ICU prior to study treatment ranged from 12 hours to 96 hours between the studies, which therefore altered the baseline risk of delirium; secondly, although all the studies used the confusion assessment method for the intensive care unit (CAM‐ICU), the frequency of assessments and the follow‐up periods were different; thirdly, even within same study the frequency might vary between groups, because a successful CAM‐ICU assessment was highly dependent on the participant's sedation level (within a RASS score of ‐3 or ehighermrhigher), which may explain in <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> why more CAM‐ICU assessments were performed in the dexmedetomidine group than in the standard care group. Furthermore, because the sensitivity of the CAM‐ICU is poor (<a href="./references#CD010269-bbs2-0128" title="VanEijkMM , Van denBoogaardM , VanMarumRJ , BennerP , EikelenboomP , HoningML , et al. Routine use of the confusion assessment method for the intensive care unit: a multicenter study. American Journal of Respiratory and Critical Care Medicine 2011;184(3):340‐4. [PUBMED: 21562131] ">Van Eijk 2011</a>), interpreting a positive CAM‐ICU assessment as an occurrence of delirium might overestimate the incidence and increase the uncertainty of the intervention effects. </p> <p><a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a> showed that dexmedetomidine reduced the risk of coma and increased the number of ICU days without coma. However, because of its long half‐life, continuous infusion of lorazepam, which was used in the control group, could result in higher concentrations and could induce deeper sedation (<a href="./references#CD010269-bbs2-0073" title="DeWitM , BestAM , EpsteinSK , GreenblattDJ . Lorazepam concentrations, pharmacokinetics and pharmacodynamics in a cohort of mechanically ventilated ICU patients. International Journal of Clinical Pharmacology and Therapeutics2006;44(10):466‐73. [PUBMED: 17063976] ">De Wit 2006</a>). On the one hand, such methodological limitation might increase the risk of iatrogenic coma (oversedation) in the control group, especially where the investigators assessed the sedation level infrequently (twice daily), but on the other hand dexmedetomidine caused less oversedation, even without frequent adjustment. </p> <p>Bradycardia was the most commonly‐reported adverse event. Our meta‐analysis found that dexmedetomidine doubled the incidence of bradycardia. Subgroup analysis indicated that the risk ratio might differ depending on which alternatives were used as the comparator. For example, the risk ratio in the propofol subgroup was lower than in the benzodiazepine derivatives subgroup, probably because propofol itself could also induce bradycardia (<a href="./references#CD010269-bbs2-0085" title="HashibaE , HirotaK , SuzukiK , MatsukiA . Effects of propofol on bronchoconstriction and bradycardia induced by vagal nerve stimulation. Acta Anaesthesiologica Scandinavica2003;47(9):1059‐63. [PUBMED: 12969095] ">Hashiba 2003</a>). <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> showed the risk of bradycardia requiring an intervention (including readjusting or interruption of study drugs and use of atropine) in the dexmedetomidine group was low (4.9%) and not significantly increased. The bradycardiac effect of dexmedetomidine might therefore be mild. We did not find an increase in the risk of hypotension or hypertension. We included tachycardia, first‐degree atrioventricular block, hyperglycaemia and hypoglycaemia, which were reported to be significant in at least one study, as outcomes of adverse events post hoc. The results of the post hoc adverse events were inconsistent among studies, probably due to the different comparators. Because of the small number of studies, there was insufficient power to investigate any impact of these rare adverse events. </p> <p>With respect to other secondary outcomes, we found dexmedetomidine was at least as effective as traditional sedatives on maintaining the target sedation level. In <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>, among participants with a target RASS score of ‐4 compared with ‐3 to 0, those on dexmedetomidine spent less time at target level than did those on standard care, which implies that dexmedetomidine may be a poor sedative choice when deep sedation is needed. Additionally, in both <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> and <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>, approximately one in every eight to ten participants ceased participation due to lack of efficacy, even on the maximum dose, and hence these two studies may overestimate the effectiveness of dexmedetomidine. Lack of blinding in some studies (<a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>; <a href="./references#CD010269-bbs2-0007" title="XuJB , WangYZ , ShiQS . A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit [右美托咪啶联合用药新方案用于重症医学科长时间镇静的研究]. Modern Medicine Journal of China2012;14(12):20‐2. ">Xu 2012</a>) would also have an unpredictable impact on this subjective outcome. We failed to identify any evidence for reducing duration of weaning. </p> <p>Our meta‐analysis provides no evidence that dexmedetomidine had any impact on overall mortality. On the one hand the adverse events which might potentially influence haemodynamic stability, such as bradycardia and hypotension, did not contribute to an increase in mortality, while on the other it would seem that choosing sedatives still occurs 'downstream' in a framework of intensive care, and has limited effect on the prognosis for survival. </p> <p>When we compared dexmedetomidine sedation in our review to 'no sedation protocol' in <a href="./references#CD010269-bbs2-0121" title="StromT , MartinussenT , ToftP . A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet2010;375(9713):475‐80. [PUBMED: 20116824] ">Strom 2010</a>, we found some common patterns which might result in reduced ventilation time: using analgesia‐based sedation, retaining some degree of participant's cognitive function, and providing on‐demand pain control. It is also clear that dexmedetomidine was a more 'professional' sedative than the morphine used in the 'no sedation protocol'. A cost‐minimization analysis of <a href="./references#CD010269-bbs2-0004" title="RikerRR , ShehabiY , BokeschPM , CerasoD , WisemandleW , KouraF , et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA2009;301(5):489‐99. [PUBMED: 19188334] ">Riker 2009</a> showed that dexmedetomidine could reduce total intensive care unit costs by about USD 10,000, because of decreased mechanical ventilation costs and ICU stay costs (<a href="./references#CD010269-bbs2-0072" title="DastaJF , Kane‐GillSL , PencinaM , ShehabiY , BokeschPM , WisemandleW , et al. A cost‐minimization analysis of dexmedetomidine compared with midazolam for long‐term sedation in the intensive care unit. Critical Care Medicine2010;38(2):497‐503. [PUBMED: 19789442] ">Dasta 2010</a>). All these properties of dexmedetomidine seemed to make it a cost‐effective choice for ICU sedation. But we must also consider any negative aspects to offset the beneficial effects. Firstly, patients might request additional sedatives or analgesics because they could express discomfort (<a href="./references#CD010269-bbs2-0009" title="CorbettSM , RebuckJA , GreeneCM , CallasPW , NealeBW , HealeyMA , et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Critical Care Medicine2005;33(5):940‐5. [PUBMED: 15891317] ">Corbett 2005</a>; <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>; <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>; <a href="./references#CD010269-bbs2-0101" title="MaclarenR , PreslaskiCR , MuellerSW , KiserTH , FishDN , LavelleJC , et al. A randomized, double‐blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short‐term psychological outcomes. Journal of Intensive Care Medicine2013 [Epub ahead of print]. [PUBMED: 24227448] ">Maclaren 2013</a>). Secondly, despite a theoretical advantage of dexmedetomidine in providing nature‐like sleep, patients on dexmedetomidine were more likely to have sleeping difficulties (<a href="./references#CD010269-bbs2-0009" title="CorbettSM , RebuckJA , GreeneCM , CallasPW , NealeBW , HealeyMA , et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Critical Care Medicine2005;33(5):940‐5. [PUBMED: 15891317] ">Corbett 2005</a>; <a href="./references#CD010269-bbs2-0108" title="OtoJ , YamamotoK , KoikeS , OnoderaM , ImanakaH , NishimuraM . Sleep quality of mechanically ventilated patients sedated with dexmedetomidine. Intensive Care Medicine2012;38(12):1982‐9. [PUBMED: 22961436] ">Oto 2012</a>). Thirdly, a recent study focusing on psychological outcomes showed that dexmedetomidine was associated with greater recall of ICU experiences and higher risk of acute stress disorder (<a href="./references#CD010269-bbs2-0101" title="MaclarenR , PreslaskiCR , MuellerSW , KiserTH , FishDN , LavelleJC , et al. A randomized, double‐blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short‐term psychological outcomes. Journal of Intensive Care Medicine2013 [Epub ahead of print]. [PUBMED: 24227448] ">Maclaren 2013</a>). As more frequent assessment of discomfort or pain and appropriate supplemental sedatives or analgesic would be needed, dexmedetomidine for sedation might potentially increase the workload for medical staff. </p> </section> <section id="CD010269-sec-0085"> <h3 class="title" id="CD010269-sec-0085">Overall completeness and applicability of evidence</h3> <p>Although the results of our meta‐analyses seem to support beneficial outcomes for the use of alpha‐2 agonists for long‐term sedation, there were several limitations. Firstly, the included studies investigated only adults treated with dexmedetomidine. Our findings therefore should not be extrapolated to children or to patients treated with clonidine. Secondly, none of the studies described in sufficient detail how they predicted that a patient would require long‐term ventilation and sedation. We believe that clinicians in different healthcare system may have different opinions on this point, so that the participants in our review might be substantially different from those in other healthcare systems. Thirdly, most studies excluded people with severe bradycardia, second‐ or third‐degree atrioventricular conduction block or hepatic impairment, and used a dose of dexmedetomidine of no more than 1.5 mcg/kg per hour. Thus, it was not clear whether dexmedetomidine could be used safely in these excluded patients, or whether it could safely be used in higher doses. Fourthly, most studies incorporated new ICU sedation strategies which were recommended by recent guideline (<a href="./references#CD010269-bbs2-0062" title="BarrJ , FraserGL , PuntilloK , ElyEW , GélinasC , DastaJF , et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Critical Care Medicine2013;41(1):263‐306. [PUBMED: 23269131] ">Barr 2013</a>): light level of sedation protocols, daily interruptions, analgesia‐based sedation and monitoring of delirium. It is unclear whether our findings can be generalized to other healthcare systems where these revised sedation strategies do not apply. </p> </section> <section id="CD010269-sec-0086"> <h3 class="title" id="CD010269-sec-0086">Quality of the evidence</h3> <p>In our systematic review, six of the seven studies were at high risk of bias across the six domains (Figure 3). As a consequence, the general quality of evidence ranged from very low to low, based on the GRADE system (<a href="./full#CD010269-tbl-0001">summary of findings Table for the main comparison</a>). We noted several methodological limitations in the included studies. Firstly, the risk of breaking blinding might be high, even when double‐blinding and a double‐dummy design were used. <a href="./references#CD010269-bbs2-0134" title="WunschH . Weighing the costs and benefits of a sedative. JAMA2012;307(11):1195‐7. [PUBMED: 22436960] ">Wunsch 2012</a> has pointed out that when the comparator was propofol, even a single drop visible at the end of an infusion would break the blinding. We also suspect that a sophisticated clinician could easily guess the identity of the study drugs from the bradycardiac effect of dexmedetomidine. Secondly, high withdrawal rates in some studies might bias the overall results, especially in <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> and <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a>, where more than 20% of participants withdrew from each study group. Most reasons for withdrawal were unbalanced between the groups and were related to outcomes, such as lack of efficacy and adverse events, which might lead to an underestimate of the adverse consequences and might have unpredictable impacts on the other outcomes. Thirdly, some participants from <a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a>, <a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> and <a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> received continuous sedation prior to the study treatment. The carry‐over effect of preceding sedation might reduce the required dosages of dexmedetomidine and have unpredictable impacts on the intervention effect. </p> </section> <section id="CD010269-sec-0087"> <h3 class="title" id="CD010269-sec-0087">Potential biases in the review process</h3> <p>There were several potential biases in the review process which should be reiterated. Firstly, our systematic review includes only seven studies, and thus we were not able to generate funnel plots or to assess publication bias by using the Egger test and the arcsine test. Secondly, we emailed the first and corresponding authors of all seven included studies twice, but received only two responses (<a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a>; <a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>), with one providing study data (<a href="./references#CD010269-bbs2-0006" title="ShehabiY , BellomoR , ReadeMC , BaileyM , BassF , HoweB , et al. Early goal‐directed sedation versus standard sedation in mechanically ventilated critically III patients: A pilot study. Critical Care Medicine2013;41(8):1983‐91. [PUBMED: 23863230] ">Shehabi 2013</a>). In the absence of individual patient data or log‐transformed data, we estimated means using medians. We do not consider that this estimation would excessively influence the results of the meta‐analyses, since log‐transformed means will be approximately equal to log‐transformed median under the assumption that the log‐transformation of the raw data may substantially reduce skew. Thirdly, due to small numbers of included studies, our predefined subgroup analyses might be underpowered to explore and eliminate heterogeneity. </p> </section> <section id="CD010269-sec-0088"> <h3 class="title" id="CD010269-sec-0088">Agreements and disagreements with other studies or reviews</h3> <p>Previous meta‐analyses have investigated the effect of dexmedetomidine in an ICU setting. <a href="./references#CD010269-bbs2-0122" title="TanJA , HoKM . Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta‐analysis. Intensive Care Medicine2010;36(6):926‐39. [PUBMED: 20376429] ">Tan 2010</a> reached similar conclusions to our findings for the ICU length of stay, risk of delirium and adverse events, but not for duration of mechanical ventilation. Two meta‐analyses comparing propofol head‐to‐head with dexmedetomidine both suggested that dexmedetomidine did not reduce ventilation time (<a href="./references#CD010269-bbs2-0135" title="XiaZQ , ChenSQ , YaoX , XieCB , WenSH , LiuKX . Clinical benefits of dexmedetomidine versus propofol in adult intensive care unit patients: a meta‐analysis of randomized clinical trials. Journal of Surgical Research2013;185(2):833‐43. [PUBMED: 23910886] ">Xia 2013</a>; <a href="./references#CD010269-bbs2-0136" title="ZhuoS , ZhengJ , LluB . Sedative effect of dexmedetomidine versus propofol on postoperative patients in ICU: a systematic review. Chinese Journal of Evidence‐Based Medicine2012;12(6):686‐93. [EMBASE: 2012409765] ">Zhuo 2012</a>). One reported that dexmedetomidine reduced the risk of delirium (<a href="./references#CD010269-bbs2-0136" title="ZhuoS , ZhengJ , LluB . Sedative effect of dexmedetomidine versus propofol on postoperative patients in ICU: a systematic review. Chinese Journal of Evidence‐Based Medicine2012;12(6):686‐93. [EMBASE: 2012409765] ">Zhuo 2012</a>), which was confirmed in our subgroup analysis. Another meta‐analysis (<a href="./references#CD010269-bbs2-0099" title="LinYY , HeB , ChenJ , WangZN . Can dexmedetomidine be a safe and efficacious sedative agent in post‐cardiac surgery patients? A meta‐analysis. Critical Care2012;16(5):R169. [PUBMED: 23016926] ">Lin 2012</a>) compared dexmedetomidine with placebo or traditional sedatives in the setting of a post‐cardiac surgery unit and found that dexmedetomidine reduced ventilation time and risk of delirium. However, this review included both randomized controlled trials and cohort studies, which may have increased heterogeneity and the risk of publication bias. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010269-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Selection process for studies included in data synthesis." data-id="CD010269-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Selection process for studies included in data synthesis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010269-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010269-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 1 Duration of mechanical ventilation (subgroup: class of alternative agents)." data-id="CD010269-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 1 Duration of mechanical ventilation (subgroup: class of alternative agents). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 2 Duration of mechanical ventilation (sensitivity analysis using data from 'time to extubation'&quot;)." data-id="CD010269-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 2 Duration of mechanical ventilation (sensitivity analysis using data from 'time to extubation'"). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 3 Risk of delirium (subgroup: class of alternative agents)." data-id="CD010269-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 3 Risk of delirium (subgroup: class of alternative agents). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 4 Risk of delirium (sensitivity analysis for observed data only)." data-id="CD010269-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 4 Risk of delirium (sensitivity analysis for observed data only). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 5 Incidence of bradycardia (subgroup: class of alternative agents)." data-id="CD010269-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 5 Incidence of bradycardia (subgroup: class of alternative agents). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 6 Incidence of bradycardia (subgroup: dosing regimens)." data-id="CD010269-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 6 Incidence of bradycardia (subgroup: dosing regimens). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 7 Incidence of bradycardia (sensitivity analysis for observed data only)." data-id="CD010269-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 7 Incidence of bradycardia (sensitivity analysis for observed data only). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 8 Incidence of hypotension (subgroup: class of alternative agents)." data-id="CD010269-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 8 Incidence of hypotension (subgroup: class of alternative agents). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 9 Incidence of hypotension (subgroup: dosing regimens)." data-id="CD010269-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 9 Incidence of hypotension (subgroup: dosing regimens). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 10 Incidence of hypotension (sensitivity analysis for observed data only)." data-id="CD010269-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 10 Incidence of hypotension (sensitivity analysis for observed data only). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0014"> <p> <div class="table" id="CD010269-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexmedetomidine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Traditional sedatives</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jakob 2012 MIDEX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56.6%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jakob 2012 PRODEX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.7%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pandharipande 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80% (nurse); 67% (physician)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67% (nurse); 55% (physician)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Riker 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.1%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ruokonen 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shehabi 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Xu 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.6%</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 11 Proportion of sedation time spent at target sedation level. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0014">Navigate to figure in review</a></div> </div> <div class="figure" id="CD010269-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 12 ICU length of stay (LOS) (subgroup: class of alternative agents)." data-id="CD010269-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 12 ICU length of stay (LOS) (subgroup: class of alternative agents). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 13 Mortality (subgroup: class of alternative agents)." data-id="CD010269-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 13 Mortality (subgroup: class of alternative agents). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010269-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/urn:x-wiley:14651858:media:CD010269:CD010269-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_t/tCD010269-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 14 Mortality (sensitivity analysis for observed data only)." data-id="CD010269-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus traditional sedative agents, Outcome 14 Mortality (sensitivity analysis for observed data only). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/media/CDSR/CD010269/image_n/nCD010269-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010269-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Dexmedetomidine compared to traditional sedative agents for long‐term sedation during mechanical ventilation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Dexmedetomidine compared to traditional sedative agents for long‐term sedation during mechanical ventilation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Critically ill patients requiring long‐term sedation during mechanical ventilation<br/> <b>Settings:</b> ICUs<br/> <b>Intervention:</b> Dexmedetomidine<br/> <b>Comparison:</b> traditional sedative agents </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>traditional sedative agents</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Dexmedetomidine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of mechanical ventilation</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Relative decrease 22% in the geometric mean (95% CI 10% to 33%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1120<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Alpha‐2 agonists reduced geometric mean duration of mechanical ventilation by 0.25 (95% CI 0.10 to 0.40), corresponding to a reduction of 22% in the geometric mean (95% CI 10% to 33%). The relative change in geometric means usually produces similar results to the relative change in arithmetic means. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Risk of delirium</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 0.85<br/> (0.63 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1624<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3,4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>‐</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>266 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>226 per 1000<br/> (167 to 303) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>76 per 1000 <sup>8</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000<br/> (48 to 87) <sup>8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>824 per 1000 <sup>8</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>700 per 1000<br/> (519 to 939) <sup>8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of coma</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.69<br/> (0.55 to 0.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>103<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1,2,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>922 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>636 per 1000<br/> (507 to 793) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Incidence of bradycardia</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>RR 2.11<br/> (1.39 to 3.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1587<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>10,7,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000<br/> (124 to 287) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>39 per 1000 <sup>8</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000<br/> (54 to 125) <sup>8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>188 per 1000 <sup>8</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>397 per 1000<br/> (261 to 602) <sup>8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of weaning</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only one study assessed this outcome and only reported median and range. We were not able to estimate a relative effect. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU length of stay</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Relative decrease 14% in the geometric mean (95% CI 0.01% to 24%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1223<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1,11,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation using alpha‐2 agonists reduced geometric mean ICU LOS by 0.15 (95% CI 0.01 to 0.28), corresponding to a reduction of 14% in the geometric mean (95% CI 0.01% to 24%). Relative change in geometric means usually produces similar results to the relative change in arithmetic means. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.99<br/> (0.79 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1584<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>10,5,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>205 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1000<br/> (162 to 254) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>192 per 1000 <sup>12</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>190 per 1000<br/> (152 to 238) <sup>12</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 1 point due to all the studies being at high risk of bias, which was considered very serious. </p> <p><sup>2</sup>Downgraded by 1 point because all the studies received funding support from pharmaceutical firms and thus publication bias was strongly suspected. </p> <p><sup>3</sup>Downgraded by 1 point due to 6 of the 7 studies being at high risk of bias, which was considered serious. </p> <p><sup>4</sup>Downgraded by 1 point because the heterogeneity is substantial and thus inconsistency was serious. </p> <p><sup>5</sup>Downgraded by 1 point because results were consistent with both no effect and appreciable benefit, and thus imprecision was serious. </p> <p><sup>6</sup>Downgraded by 1 point because 6 of the 7 studies received funding support from pharmaceutical firms and thus publication bias was strongly suspected. </p> <p><sup>7</sup>Downgraded by 1 point because the sample size was small (less than 2000) and thus inconsistency was serious. </p> <p><sup>8</sup>The baseline risk varies broadly among studies, and thus we chose the lowest and highest control group risk in the included studies. </p> <p><sup>9</sup>Downgraded by 1 point due to 5 of the 6 studies being at high risk of bias, which was considered serious. </p> <p><sup>10</sup>Downgraded by 1 point because 5 of the 6 studies received funding support from pharmaceutical firms and thus publication bias was strongly suspected. </p> <p><sup>11</sup>Downgraded by 1 point due to wide confidence interval, although there may still be enough precision to make decisions about the utility of the intervention. </p> <p><sup>12</sup>There was little variation in the baseline risk across the studies, and thus we calculated the median control group risk. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Dexmedetomidine compared to traditional sedative agents for long‐term sedation during mechanical ventilation in critically ill patients</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010269-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Calculation from median/interquartile range to geometric mean/standard deviation (SD)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Median</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interquartile range</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Geometric mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Geometric SD</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Duration of mechanical ventilation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>123 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67 ‐ 337 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.812</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.197</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>164 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92 ‐ 380 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.051</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Duration of mechanical ventilation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45 ‐ 257 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.291</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>118 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 ‐ 327 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.771</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.421</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Duration of mechanical ventilation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.2 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.5 – 338.8 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.195</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110.6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.1 – 675.0 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.603</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0001" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 MIDEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>ICU LOS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8 days (211 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8 ‐ 34.6 days (115 ‐ 831 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.465</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.1 days (243 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8 ‐ 26.2 days (140 ‐ 630 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.114</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0002" title="JakobSM , RuokonenE , GroundsRM , SarapohjaT , GarrattC , PocockSJ , et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA2012;307(11):1151‐60. [PUBMED: 22436955] ">Jakob 2012 PRODEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>ICU LOS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8 days (164 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8 ‐ 20.0 days (90 ‐ 480 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.922</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7 days (185 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.9 ‐ 21.7 days (93 ‐ 520 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.275</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0003" title="PandharipandePP , PunBT , HerrDL , MazeM , GirardTD , MillerRR , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA2007;298(22):2644‐53. [PUBMED: 18073360] ">Pandharipande 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>ICU LOS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 ‐ 19 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.989</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 ‐ 15 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.679</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010269-bbs2-0005" title="RuokonenE , ParviainenI , JakobSM , NunesS , KaukonenM , ShepherdST , et al. Dexmedetomidine versus propofol/midazolam for long‐term sedation during mechanical ventilation. Intensive Care Medicine2009;35(2):282‐90. [PUBMED: 18795253] ">Ruokonen 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>ICU LOS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7 – 19.5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.705</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.807</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7 – 29.0 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.101</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>ICU: intensive care unit<br/> LOS: length of stay </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Calculation from median/interquartile range to geometric mean/standard deviation (SD)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010269-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Meta‐regression for incidence of delirium on geometric mean ventilation time</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>tau²</b> (estimated amount of residual heterogeneity) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1460 (SE = 0.1596)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>tau</b> (square root of estimated tau² value) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3820</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>I²</b> (residual heterogeneity / unaccounted variability) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.09%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>H²</b> (unaccounted variability / sampling variability) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>R²</b> (amount of heterogeneity accounted for) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.00%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intercept</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0895 (95% CI ‐5.4218 to 5.6007, P = 0.9746)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Coefficient for log‐transformed mean ventilation time</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.0442 (95% CI ‐1.1989 to 1.1105, P = 0.9403)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Meta‐regression for incidence of delirium on geometric mean ventilation time</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/full#CD010269-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010269-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Dexmedetomidine versus traditional sedative agents</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of mechanical ventilation (subgroup: class of alternative agents) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.40, ‐0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Benzodiazepine derivatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.49, ‐0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>498</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.43, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Standard care (propofol and midazolam)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐1.26, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Duration of mechanical ventilation (sensitivity analysis using data from 'time to extubation'") <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐0.49, ‐0.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Risk of delirium (subgroup: class of alternative agents) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1624</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.63, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Benzodiazepine derivatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.59, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.16, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Standard care (propofol and midazolam)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.86, 2.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Risk of delirium (sensitivity analysis for observed data only) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1621</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.63, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Incidence of bradycardia (subgroup: class of alternative agents) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [1.39, 3.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Benzodiazepine derivatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.44 [1.77, 3.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.74, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Standard care (propofol and midazolam)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.50 [0.40, 140.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Incidence of bradycardia (subgroup: dosing regimens) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [1.39, 3.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Rapid dosing regimens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.00 [0.52, 156.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Slow dosing regimens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [1.35, 3.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Incidence of bradycardia (sensitivity analysis for observed data only) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1584</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [1.39, 3.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Incidence of hypotension (subgroup: class of alternative agents) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.86, 1.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Benzodiazepine derivatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.77, 2.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.62, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Standard care (propofol and midazolam)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.15 [0.20, 22.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Incidence of hypotension (subgroup: dosing regimens) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.86, 1.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Rapid dosing regimens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.00 [0.52, 156.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Slow dosing regimens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.86, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Incidence of hypotension (sensitivity analysis for observed data only) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1584</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.86, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Proportion of sedation time spent at target sedation level <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 ICU length of stay (LOS) (subgroup: class of alternative agents) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.28, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Benzodiazepine derivatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>603</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.34, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>498</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.34, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Standard care (propofol and midazolam)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.69, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Mortality (subgroup: class of alternative agents) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1584</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.79, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Benzodiazepine derivatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>967</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.68, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.55, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 Standard care (propofol and midazolam)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.67, 3.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Mortality (sensitivity analysis for observed data only) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.78, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Dexmedetomidine versus traditional sedative agents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010269.pub2/references#CD010269-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010269.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010269-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010269-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010269-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD010269-note-0001">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD010269-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010269-note-0004">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010269\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010269\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010269\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010269\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010269\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010269.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010269.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010269.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010269.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010269.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714298242"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010269.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714298246"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010269.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6b419cb5f3cd',t:'MTc0MDcxNDI5OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 